Studie Pharmamarketing / Pharmavertrieb

Marktanalyse - ICT budget forecasts in Large Danish Pharmaceutical Companies - Estimated ICT budget breakdowns in 2013

Synopsis
This report illustrates how Kable expects Large Danish Pharmaceutical Companies to allocate their ICT budgets across the core areas of enterprise ICT spend, namely hardware, software, IT services, telecommunications and consulting.

Summary
Why was the report written?
This re... mehr

Marktanalyse - ICT budget forecasts in Large Finnish Pharmaceutical Companies - Estimated ICT budget breakdowns in 2013

Synopsis
This report illustrates how Kable expects Large Finnish Pharmaceutical Companies to allocate their ICT budgets across the core areas of enterprise ICT spend, namely hardware, software, IT services, telecommunications and consulting.

Summary
Why was the report written?
This ... mehr

Marktanalyse - ICT budget forecasts in Medium-sized Danish Pharmaceutical Companies - Estimated ICT budget breakdowns in 2013

Synopsis
This report illustrates how Kable expects Medium-sized Danish Pharmaceutical Companies to allocate their ICT budgets across the core areas of enterprise ICT spend, namely hardware, software, IT services, telecommunications and consulting.

Summary
Why was the report written... mehr

Marktanalyse - ICT budget forecasts in Medium-sized Finnish Pharmaceutical Companies - Estimated ICT budget breakdowns in 2013

Synopsis
This report illustrates how Kable expects Medium-sized Finnish Pharmaceutical Companies to allocate their ICT budgets across the core areas of enterprise ICT spend, namely hardware, software, IT services, telecommunications and consulting.

Summary
Why was the report writt... mehr

Marktanalyse - ICT budget forecasts in Small Danish Pharmaceutical Companies - Estimated ICT budget breakdowns in 2013

Synopsis
This report illustrates how Kable expects Small Danish Pharmaceutical Companies to allocate their ICT budgets across the core areas of enterprise ICT spend, namely hardware, software, IT services, telecommunications and consulting.

Summary
Why was the report written?
This re... mehr

Marktanalyse - ICT budget forecasts in Small Finnish Pharmaceutical Companies - Estimated ICT budget breakdowns in 2013

Synopsis
This report illustrates how Kable expects Small Finnish Pharmaceutical Companies to allocate their ICT budgets across the core areas of enterprise ICT spend, namely hardware, software, IT services, telecommunications and consulting.

Summary
Why was the report written?
This ... mehr

Consumer health maintained a strong growth trend in 2012, following on from the previous two years. This growing trend is recorded for the entire Argentine Pharmaceutical Industry, according to the latest reports issued by INDEC (National Institute of Statistics and Census) as regards the same period in 2011.

Euromonitor International's Consumer Health in Argentina report offers a comprehensive guide to the size and shape of... mehr

Consumer health maintained a strong growth trend in 2012, following on from the previous two years. This growing trend is recorded for the entire Argentine Pharmaceutical Industry, according to the latest reports issued by INDEC (National Institute of Statistics and Census) as regards the same period in 2011.

Euromonitor International's Consumer Health in Argentina report offers a comprehensive guide to the size and shape of... mehr

Bottled water consumption in Colombia was, before 2012, importantly based on a fundamental need and convenience (except for niche-oriented carbonated natural mineral bottled water brands such as Perrier and S Pellegrino) more than on a demand for additional benefits as has happened in other soft drinks categories thanks to the increase of fortified and functional products. The lack of safe water supply in vast regions of the country has... mehr

Current value sales of consumer health increased in Denmark in 2012. In comparison to earlier years of the review period, sales marginally improved, with the main categories, such as analgesics, digestive remedies and dermatologicals all recording growth in 2012. Less dominant categories in consumer health, such as NRT smoking cessation aids and calming and sleeping, experienced a decline in value sales. A relatively improved economic c... mehr

Consumer health saw weaker value growth in 2012 when compared to the results achieved in the review period. In 2012 the category posted value growth of 7% in current terms, while the CAGR of the review period was 8%. However, the category is still showing a healthy performance, mainly driven by an increased consumer base, since a rising number of consumers are becoming more familiar with these products and have higher disposable incomes... mehr

As affordable necessities in Chinese consumers’ daily lives, hosiery in China was less affected by the economic downturn compared with other apparel categories like men’s and women’s clothing in 2012. Immune from the economic recession, hosiery continued to witness dynamic growth in 2012 with retail value grew by 14%, which was higher than historical CAGR of 10% over the review period.

Euromonitor International's Hosier... mehr

Consumer health in Norway increased by 3% in current value terms in 2012; this was lower than the review period CAGR. The economic crisis in Europe in 2009 and 2011 was not able to affect spending, because consumer health is not very sensitive to economic fluctuations and financial crises. The largest categories, such as vitamins and dietary supplements and OTC products, saw modest growth in constant value terms, due to strong price com... mehr

Consumer health in Norway increased by 3% in current value terms in 2012; this was lower than the review period CAGR. The economic crisis in Europe in 2009 and 2011 was not able to affect spending, because consumer health is not very sensitive to economic fluctuations and financial crises. The largest categories, such as vitamins and dietary supplements and OTC products, saw modest growth in constant value terms, due to strong price com... mehr

Demand for consumer health in Tunisia increased strongly during 2012 as the industry enjoyed the highest growth in its history. The 11% value growth recorded in consumer health over the course of 2012 was due to a record rise in volume sales in the industry following, which itself was the result of several phenomena such as a sudden population increase due to an influx of people from troubled neighbour Libya and record-breaking cold tem... mehr

In 2012, vending continued to experience a fall in retail value sales. Consumers started to reduce their expenditure in 2009, as a result of the outbreak of the financial crisis in late 2008, and this attitude persisted until the end of the review period as the economic situation deteriorated. In 2012, vending registered a 2% decline in current value sales to reach CZK1.8 billion.

Euromonitor International's Vending in Czech ... mehr

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - France


Summary


GlobalData, the industry analysis specialist, has released its new report, 'CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - France”. The report is an essential source of information and an analysis on the healthcare, regulatory and reimbursement landscape of France. The report identifies the key trends... mehr

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Italy


Summary


GlobalData, the industry analysis specialist, has released its new report, 'CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Italy”. The report is an essential source of information and analysis on Italy’s healthcare, regulatory and reimbursement landscape. It identifies the key trends in the healthcar... mehr

Marktanalyse - ICT budget forecasts in Large Norwegian Pharmaceuticals - Estimated ICT budget breakdowns in 2013

Synopsis
This report illustrates how Kable expects Large Norwegian Pharmaceuticals to allocate their ICT budgets across the core areas of enterprise ICT spend, namely hardware, software, IT services, telecommunications and consulting.

Summary
Why was the report written?
This report present... mehr

Marktanalyse - ICT budget forecasts in Medium-sized Norwegian Pharmaceuticals - Estimated ICT budget breakdowns in 2013

Synopsis
This report illustrates how Kable expects Medium-sized Norwegian Pharmaceuticals to allocate their ICT budgets across the core areas of enterprise ICT spend, namely hardware, software, IT services, telecommunications and consulting.

Summary
Why was the report written?
This ... mehr

Marktanalyse - ICT budget forecasts in Small Norwegian Pharmaceuticals - Estimated ICT budget breakdowns in 2013

Synopsis
This report illustrates how Kable expects Small Norwegian Pharmaceuticals to allocate their ICT budgets across the core areas of enterprise ICT spend, namely hardware, software, IT services, telecommunications and consulting.

Summary
Why was the report written?
This report present... mehr

Marktanalyse - ICT Spend Predictions in Large Brazilian Pharmaceutical Companies - Estimated ICT budget breakdowns in 2013

Synopsis
This report illustrates how Kable expects Large Brazilian Pharmaceutical Companies to allocate their ICT budgets across the core areas of enterprise ICT spend, namely hardware, software, IT services, telecommunications and consulting.

Summary
Why was the report written?
... mehr

Marktanalyse - ICT Spend Predictions in Large Canadian Pharmaceutical Companies - Estimated ICT budget breakdowns in 2013

Synopsis
This report illustrates how Kable expects Large Canadian Pharmaceutical Companies to allocate their ICT budgets across the core areas of enterprise ICT spend, namely hardware, software, IT services, telecommunications and consulting.

Summary
Why was the report written?
Th... mehr

Marktanalyse - ICT Spend Predictions in Large French Pharmaceutical Companies - Estimated ICT budget breakdowns in 2013

Synopsis
This report illustrates how Kable expects Large French Pharmaceutical Companies to allocate their ICT budgets across the core areas of enterprise ICT spend, namely hardware, software, IT services, telecommunications and consulting.

Summary
Why was the report written?
This r... mehr

Marktanalyse - ICT Spend Predictions in Large German Pharmaceutical Companies - Estimated ICT budget breakdowns in 2013

Synopsis
This report illustrates how Kable expects Large German Pharmaceutical Companies to allocate their ICT budgets across the core areas of enterprise ICT spend, namely hardware, software, IT services, telecommunications and consulting.

Summary
Why was the report written?
This r... mehr

Marktanalyse - ICT Spend Predictions in Large Mexican Pharmaceutical Companies - Estimated ICT budget breakdowns in 2013

Synopsis
This report illustrates how Kable expects Large Mexican Pharmaceutical Companies to allocate their ICT budgets across the core areas of enterprise ICT spend, namely hardware, software, IT services, telecommunications and consulting.

Summary
Why was the report written?
This... mehr

Marktanalyse - ICT Spend Predictions in Large UK Pharmaceutical Companies - Estimated ICT budget breakdowns in 2013

Synopsis
This report illustrates how Kable expects Large UK Pharmaceutical Companies to allocate their ICT budgets across the core areas of enterprise ICT spend, namely hardware, software, IT services, telecommunications and consulting.

Summary
Why was the report written?
This report pr... mehr

Marktanalyse - ICT Spend Predictions in Large US Pharmaceutical Companies - Estimated ICT budget breakdowns in 2013

Synopsis
This report illustrates how Kable expects Large US Pharmaceutical Companies to allocate their ICT budgets across the core areas of enterprise ICT spend, namely hardware, software, IT services, telecommunications and consulting.

Summary
Why was the report written?
This report pr... mehr

Marktanalyse - ICT Spend Predictions in Medium-sized Brazilian Pharmaceutical Companies - Estimated ICT budget breakdowns in 2013

Synopsis
This report illustrates how Kable expects Medium-sized Brazilian Pharmaceutical Companies to allocate their ICT budgets across the core areas of enterprise ICT spend, namely hardware, software, IT services, telecommunications and consulting.

Summary
Why was the report ... mehr

Marktanalyse - ICT Spend Predictions in Medium-sized Canadian Pharmaceutical Companies - Estimated ICT budget breakdowns in 2013

Synopsis
This report illustrates how Kable expects Medium-sized Canadian Pharmaceutical Companies to allocate their ICT budgets across the core areas of enterprise ICT spend, namely hardware, software, IT services, telecommunications and consulting.

Summary
Why was the report wr... mehr

Marktanalyse - ICT Spend Predictions in Medium-sized French Pharmaceutical Companies - Estimated ICT budget breakdowns in 2013

Synopsis
This report illustrates how Kable expects Medium-sized French Pharmaceutical Companies to allocate their ICT budgets across the core areas of enterprise ICT spend, namely hardware, software, IT services, telecommunications and consulting.

Summary
Why was the report writte... mehr

Marktanalyse - ICT Spend Predictions in Medium-sized German Pharmaceutical Companies - Estimated ICT budget breakdowns in 2013

Synopsis
This report illustrates how Kable expects Medium-sized German Pharmaceutical Companies to allocate their ICT budgets across the core areas of enterprise ICT spend, namely hardware, software, IT services, telecommunications and consulting.

Summary
Why was the report writte... mehr

Marktanalyse - ICT Spend Predictions in Medium-sized Mexican Pharmaceutical Companies - Estimated ICT budget breakdowns in 2013

Synopsis
This report illustrates how Kable expects Medium-sized Mexican Pharmaceutical Companies to allocate their ICT budgets across the core areas of enterprise ICT spend, namely hardware, software, IT services, telecommunications and consulting.

Summary
Why was the report writ... mehr

Marktanalyse - ICT Spend Predictions in Medium-sized UK Pharmaceutical Companies - Estimated ICT budget breakdowns in 2013

Synopsis
This report illustrates how Kable expects Medium-sized UK Pharmaceutical Companies to allocate their ICT budgets across the core areas of enterprise ICT spend, namely hardware, software, IT services, telecommunications and consulting.

Summary
Why was the report written?
... mehr

Marktanalyse - ICT Spend Predictions in Medium-sized US Pharmaceutical Companies - Estimated ICT budget breakdowns in 2013

Synopsis
This report illustrates how Kable expects Medium-sized US Pharmaceutical Companies to allocate their ICT budgets across the core areas of enterprise ICT spend, namely hardware, software, IT services, telecommunications and consulting.

Summary
Why was the report written?
... mehr

Marktanalyse - ICT Spend Predictions in Small Brazilian Pharmaceutical Companies - Estimated ICT budget breakdowns in 2013

Synopsis
This report illustrates how Kable expects Small Brazilian Pharmaceutical Companies to allocate their ICT budgets across the core areas of enterprise ICT spend, namely hardware, software, IT services, telecommunications and consulting.

Summary
Why was the report written?
... mehr

Marktanalyse - ICT Spend Predictions in Small Canadian Pharmaceutical Companies - Estimated ICT budget breakdowns in 2013

Synopsis
This report illustrates how Kable expects Small Canadian Pharmaceutical Companies to allocate their ICT budgets across the core areas of enterprise ICT spend, namely hardware, software, IT services, telecommunications and consulting.

Summary
Why was the report written?
Th... mehr

Marktanalyse - ICT Spend Predictions in Small French Pharmaceutical Companies - Estimated ICT budget breakdowns in 2013

Synopsis
This report illustrates how Kable expects Small French Pharmaceutical Companies to allocate their ICT budgets across the core areas of enterprise ICT spend, namely hardware, software, IT services, telecommunications and consulting.

Summary
Why was the report written?
This r... mehr

Marktanalyse - ICT Spend Predictions in Small German Pharmaceutical Companies - Estimated ICT budget breakdowns in 2013

Synopsis
This report illustrates how Kable expects Small German Pharmaceutical Companies to allocate their ICT budgets across the core areas of enterprise ICT spend, namely hardware, software, IT services, telecommunications and consulting.

Summary
Why was the report written?
This r... mehr

Marktanalyse - ICT Spend Predictions in Small Mexican Pharmaceutical Companies - Estimated ICT budget breakdowns in 2013

Synopsis
This report illustrates how Kable expects Small Mexican Pharmaceutical Companies to allocate their ICT budgets across the core areas of enterprise ICT spend, namely hardware, software, IT services, telecommunications and consulting.

Summary
Why was the report written?
This... mehr

Marktanalyse - ICT Spend Predictions in Small UK Pharmaceutical Companies - Estimated ICT budget breakdowns in 2013

Synopsis
This report illustrates how Kable expects Small UK Pharmaceutical Companies to allocate their ICT budgets across the core areas of enterprise ICT spend, namely hardware, software, IT services, telecommunications and consulting.

Summary
Why was the report written?
This report pr... mehr

Marktanalyse - ICT Spend Predictions in Small US Pharmaceutical Companies - Estimated ICT budget breakdowns in 2013

Synopsis
This report illustrates how Kable expects Small US Pharmaceutical Companies to allocate their ICT budgets across the core areas of enterprise ICT spend, namely hardware, software, IT services, telecommunications and consulting.

Summary
Why was the report written?
This report pr... mehr

Partnerships, Licensing, Investments and M&A Deals and Trends for April 2013 in Pharmaceuticals


Summary


GlobalData's 'Partnerships, Licensing, Investments and M&A Deals and Trends for April 2013 in Pharmaceuticals” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report p... mehr

South Korea Pharmaceutical Market Outlook 2013


Summary


GBI Research’s new report 'South Korea Pharmaceutical Market Outlook 2013” provides in-depth analysis of the trends, issues and challenges facing the South Korean pharmaceutical market. The report also provides competitive benchmarking for the country’s leading pharmaceutical companies and analyzes the M&A (Mergers and Acquisitions) and st... mehr

Consumer health maintained a stable and solid value performance over the review period until 2012. With stable unit prices, categories were able to continue to grow, enabled by higher buying power after a rise in minimum wages in 2012. Categories with higher profit margins, such as vitamins and dietary supplements witnessed strong growth, boosted by new product developments and higher consumer interest in general health and well-being.<... mehr

Consumer health retail value sales recorded positive growth in 2012, due to the good performance of vitamins and dietary supplements and sports nutrition. This growth was driven by success in dietary supplements, especially in combination products which offer various benefits in just one product. Increasing perception of dietary supplements as a safe way to improve health and prevent diseases and boost energy — necessary in coping... mehr

China’s consumer healthcare industry registered slower value sales growth in 2012 than in 2011, which was consistent with the general slowdown in most consumer goods industries in China, chiefly brought about by the continuing global economic difficulties. 2012 witnessed lower national GDP than in previous years, and a decline in consumer confidence also contributed to the slowdown in growth in China’s consumer health industry durin... mehr

The consumer health market in Finland did not only face the challenge of maturity, but also started to see effects from the economic downturn once again in 2012, as consumers were feeling more insecure about their purchasing power. Nonetheless, although some categories were struggling with static value growth, some younger categories saw healthy if not dynamic growth in the course of 2012.

Euromonitor International's Consumer... mehr

Consumer health witnessed declining value sales in 2012, unable to escape the general downturn of the Greek economy. Whilst the sector had managed to maintain a positive growth over the review period, with switches and price increases fuelling growth, this has not been the case for 2012. With prices remaining relatively stable and manufacturers abstaining from switches, value sales declined amidst the very unfavourable conditions of 201... mehr

Compared with the review period, the market in 2012 grew slightly higher in value, although it was lower compared to the previous year’s sales performance. Slightly faster growth in 2012 compared to the review period’s growth rate was achieved due to the increasing demand for expensive products; while in previous years, the double-digit growth rate was attributable mostly to the average unit price increase and general inflation rate... mehr

Rapidly recovering domestic consumption contributed to growth in consumer health sales in 2012. Higher volumes of standard products and returning demand for more expensive products supported the value sales over 2012. Ability to afford products of higher quality with specific content, which are suited better to individual needs compared to standard products, resulted in switches from mainstream products to more expensive remedies.
... mehr

Despite the second consecutive year of growth, the consumer health industry remained in a recessionary mood, judging by the actions of companies. The industry is generally considered as a stable one, resistant to external shocks of the economy. However, after deteriorating sales during the recession, firms turned to pricing as the chief tactic for competing. As a result, promotion campaigns that lasted for entire months and sometimes in... mehr

Consumer health enjoys steady development in Poland as a growing number of Poles feel confident with self-medicating. More Polish consumers understand the role of proper supplementation as well as the role of OTC medicines in preventing certain ailments. Manufacturers underpin the trend by running educational campaigns and introducing novelties on a regular basis, which help to arouse consumers’ interest and prompt purchases.
mehr

Sales of consumer health products in Sweden continue to increase despite a rapid slowdown of the Swedish economy. In 2012, consumer health saw value growth of 3% due to increasing self-medication and the ageing Swedish population. However, the growth rate was slower than the CAGR for the review period. This is primarily due to increased price competition caused by the launch of private label brands and an overcrowded pharmacy market. mehr

Despite major recalls and a weak cold and flu season further dragging down over-the-counter (OTC) sales, overall consumer health grew over 4% in 2012. Preventive health and wellness campaigns sustained strong sales in vitamins and dietary supplements, with manufacturers also introducing online assessments and mobile applications to support product selection. In addition, fitness trends and continued expansion from a niche to a mainstrea... mehr

The consumer health market in Uzbekistan continued its robust development in 2012, with double-digit current value growth. Ongoing urbanisation and solid cooperation between distributors and retailers created substantial demand for consumer health products, whilst continuously rising health awareness amongst consumers also helped to boost sales. The dynamism of consumer health was also underpinned by the steady development of the econom... mehr

Healthcare, Regulatory and Reimbursement Landscape - Argentina


Summary


Industry analysis specialist GlobalData has released its latest report 'Healthcare, Regulatory and Reimbursement Landscape - Argentina”. An essential source of information and analysis on the Argentina’s healthcare, regulatory and reimbursement landscape, it identifies the key trends in the healthcare market and provides insights... mehr

Healthcare, Regulatory and Reimbursement Landscape - Belgium


Summary


Industry analysis specialist GlobalData has released its latest report 'Healthcare, Regulatory and Reimbursement Landscape - Belgium”. An essential source of information and analysis on the Belgian healthcare, regulatory and reimbursement landscape, it identifies the key trends in the healthcare market and provides insights into the ... mehr

Japan Pharmaceutical Market Outlook - Deregulation and More Efficient New Drug Approval Process Attract Foreign Investment and Improve the Competitiveness of Japanese Players


Summary


GBI Research, the leading business intelligence provider, has released its latest research 'Japan Pharmaceutical Market Outlook - Deregulation and More Efficient New Drug Approval Process Attract Foreign Investment and Impr... mehr

Consumer health innovation is thriving, as manufacturers introduce creative new formulations, delivery formats and positionings to help people manage their unique health needs more effectively. Consumers’ busy lifestyles are driving the popularity of energy and calming products, as well as on-the-go delivery mechanisms. Economic uncertainty is creating more demand for cheaper options, while preventive treatments are addressing critica... mehr

Partnerships, Licensing, Investments and M&A Deals and Trends for March 2013 in Pharmaceuticals


Summary


GlobalData's 'Partnerships, Licensing, Investments and M&A Deals and Trends for March 2013 in Pharmaceuticals” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report p... mehr

Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals — Q1 2013


Summary


GlobalData's 'Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals — Q1 2013” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&A) and financing in the pharmaceutical and healthcare market. ... mehr

The good economic conditions prevailing in the country, with consumers’ purchasing power increasing in real terms year after year, allowed consumers to absorb price increases in several categories without reducing the volume of their purchases. The excellent performance in some of the larger categories such as analgesics, cough, cold and allergy (hay fever) remedies and weight management and the sustained good level of sales in most c... mehr

The good economic conditions prevailing in the country, with consumers’ purchasing power increasing in real terms year after year, allowed consumers to absorb price increases in several categories without reducing the volume of their purchases. The excellent performance in some of the larger categories such as analgesics, cough, cold and allergy (hay fever) remedies and weight management and the sustained good level of sales in most c... mehr

Healthcare, Regulatory and Reimbursement Landscape - Austria


Summary


Industry analysis specialist GlobalData has released its latest report, 'Healthcare, Regulatory and Reimbursement Landscape - Austria”. An essential source of information and analysis on Austria’s healthcare, regulatory and reimbursement landscape, it identifies the key trends in the healthcare market and provides insights into the... mehr

Healthcare, Regulatory and Reimbursement Landscape - Finland


Summary


Industry analysis specialist GlobalData has released its latest report, 'Healthcare, Regulatory and Reimbursement Landscape - Finland”. An essential source of information and analysis on the Finland’s healthcare, regulatory and reimbursement landscape, it identifies the key trends in the healthcare market and provides insights into... mehr

Healthcare, Regulatory and Reimbursement Landscape - Norway


Summary


GlobalData, the industry analysis specialist, has released its new report, 'Healthcare, Regulatory and Reimbursement Landscape - Norway”. The report is an essential source of information and analysis regarding the healthcare, regulatory, and reimbursement landscape in Norway. It identifies key trends in the healthcare market and provi... mehr

Healthcare, Regulatory and Reimbursement Landscape - Portugal


Summary


GlobalData, the industry analysis specialist, has released its new report, 'Healthcare, Regulatory and Reimbursement Landscape - Portugal”. The report is an essential source of information on and analysis of the healthcare, regulatory, and reimbursement landscape in Portugal. It identifies key trends in the healthcare market and pro... mehr

Healthcare, Regulatory and Reimbursement Landscape - Sweden


Summary


GlobalData, the industry analysis specialist, has released its new report 'Healthcare, Regulatory and Reimbursement Landscape - Sweden”. The report is an essential source of information and analysis on Sweden’s healthcare, regulatory and reimbursement landscape. It identifies the key trends in the healthcare market and provides insi... mehr

Partnerships, Licensing, Investments and M&A Deals and Trends for February 2013 in Pharmaceuticals


Summary


GlobalData's 'Partnerships, Licensing, Investments and M&A Deals and Trends for February 2013 in Pharmaceuticals” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The re... mehr

Pharmaceutical & Healthcare Annual Deals Analysis: M&A and Investments Trends - 2012


Summary


GlobalData's 'Pharmaceutical & Healthcare Annual Deals Analysis: M&A and Investments Trends - 2012” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&A) and financing in the pharmaceutical and healthcare market. The report provi... mehr

China Pharmaceutical Market Outlook - Government Incentives, Healthcare Reform and a Rapidly Ageing Population Provide Strong Stimulus for Growth


Summary


GBI Research’s new report: 'China Pharmaceutical Market Outlook - Government Incentives, Healthcare Reform and a Rapidly Ageing Population Provide Strong Stimulus for Growth” provides in-depth analysis of the trends, issues and challenges facing th... mehr

Marktanalyse - Global Pharmaceutical Survey 2013-2014 - Market Trends, Buyer Spend and Procurement Strategies in the Global Pharmaceutical Industry

Product Synopsis
'Global Pharmaceutical Survey 2013-2014: Market Trends, Buyer Spend and Procurement Strategies in the Global Pharmaceutical Industry” is a new report by ICD Research that analyzes how pharmaceutical industry companies' procurement expenditures, business str... mehr

Marktanalyse - Global Pharmaceutical Survey 2013-2014 - Market Trends, Marketing Spend and Sales Strategies in the Global Pharmaceutical Industry

Product Synopsis
'Global Pharmaceutical Survey 2013-2014: Market Trends, Marketing Spend and Sales Strategies in the Global Pharmaceutical Industry” is a new report by ICD Research that analyzes how pharmaceutical industry companies' media spend, marketing and sales strategi... mehr

Healthcare, Regulatory and Reimbursement Landscape - Colombia


Summary


Industry analysis specialist GlobalData has released its new report, 'Healthcare, Regulatory and Reimbursement Landscape - Colombia”. An essential source of information and analysis on the Colombian healthcare, regulatory, and reimbursement landscape, this report identifies the key trends in the healthcare market, and provides insig... mehr

Healthcare, Regulatory and Reimbursement Landscape - Egypt


Summary


GlobalData, the industry analysis specialist, has released its new report, 'Healthcare, Regulatory and Reimbursement Landscape - Egypt”. The report is an essential source of information and analysis on Egypt’s healthcare, regulatory and reimbursement landscape. It identifies the key trends in the healthcare market and provides insigh... mehr

Healthcare, Regulatory and Reimbursement Landscape - New Zealand


Summary


GlobalData, the industry analysis specialist, has released its new report, 'Healthcare, Regulatory and Reimbursement Landscape - New Zealand”. The report is an essential source of information and analysis on New Zealand`s healthcare, regulatory and reimbursement landscape. It identifies the key trends in the healthcare market and... mehr

Healthcare, Regulatory and Reimbursement Landscape - Switzerland


Summary


GlobalData, the industry analysis specialist, has released its new report, 'Healthcare, Regulatory and Reimbursement Landscape - Switzerland”. The report is an essential source of information and analysis regarding the healthcare, regulatory, and reimbursement landscape in Switzerland. It identifies key trends in the healthcare m... mehr

Healthcare, Regulatory and Reimbursement Landscape - Thailand


Summary


Industry analysis specialist GlobalData has released its new report, 'Healthcare, Regulatory and Reimbursement Landscape - Thailand”. An essential source of information and analysis on the Thai healthcare, regulatory and reimbursement landscape, it identifies the key trends in the healthcare market and provides insights into the dem... mehr

Partnerships, Licensing, Investments and M&A Deals and Trends for January 2013 in Pharmaceuticals


Summary


GlobalData's 'Partnerships, Licensing, Investments and M&A Deals and Trends for January 2013 in Pharmaceuticals” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The repo... mehr

Cosmeceuticals Market to 2018 - Technological Advances and Consumer Awareness Boost Commercial Potential for Innovative and Premium-Priced Products


Summary


Leading business intelligence provider GBI Research has released its latest research report, entitled, 'Cosmeceuticals Market to 2018 - Technological Advances and Consumer Awareness Boost Commercial Potential for Innovative and Premium-Priced Product... mehr

Healthcare, Regulatory and Reimbursement Landscape - Jordan


Summary


GlobalData, the industry analysis specialist, has released its new report, 'Healthcare, Regulatory and Reimbursement Landscape - Jordan”. The report is an essential source of information and provides an analysis of the healthcare, regulatory and reimbursement landscape of Jordan. The report identifies the key trends in the healthcare ... mehr

Indian Pharmaceutical Market Outlook - Enhanced purchasing power, rural market penetration and expanded access to healthcare attracting Big Pharma investment


Summary


GBI Research’s new report 'Indian Pharmaceutical Market Outlook - Enhanced purchasing power, rural market penetration and expanded access to healthcare attracting Big Pharma investment” provides in-depth analysis of the trends, issues a... mehr

Partnerships, Licensing, Investments and M&A Deals and Trends For December 2012 In Pharmaceuticals


Summary


GlobalData's 'Partnerships, Licensing, Investments and M&A Deals and Trends For December 2012 In Pharmaceuticals” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The re... mehr

Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals — Q4 2012


Summary


GlobalData's 'Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals — Q4 2012” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&A) and financing in the pharmaceutical and healthcare market. ... mehr

PharmaLeaders: Innovative Mid-Cap Biotechnology Benchmark Report - Financial Benchmarking, Pipeline Assessment & Competitive Analysis of Innovative Biotechs


Summary


The Innovative Mid-Cap Biotech Benchmark Report applies GlobalData’s proprietary ranking methodology to compare the competitive position of 15 innovative biotech companies on 20 financial metrics. The performances of these companies ar... mehr

Consumer health retailers are continuously innovating in an effort to adapt to new regulatory policies, demographic preferences, technological developments and public health influences. Health and wellness trends are holding a great deal of sway over everything from store formats to marketing strategies. Younger consumers seek more internet and mobile shopping options, while ageing ones require different services. Companies are finding ... mehr

Selling consumer health is seeing an impressive transformation thanks to the explosion of digital media. Although the main marketing principles remain the same, the communication platform is moving to new and innovative channels. Advertisers and marketers are experimenting with creative and engaging campaigns in a bid to attract consumption and boost revenue. An intriguing development is the rise of 'mobile health”, which may rewrite ... mehr

Selling consumer health is seeing an impressive transformation thanks to the explosion of digital media. Although the main marketing principles remain the same, the communication platform is moving to new and innovative channels. Advertisers and marketers are experimenting with creative and engaging campaigns in a bid to attract consumption and boost revenue. An intriguing development is the rise of 'mobile health”, which may rewrite ... mehr

Statins Market to 2018 - Weak Product Pipeline and Shift of Focus towards Combination Therapies will Lead to Erosion of Brand Share


Summary


GBI Research, the leading business intelligence provider, has released its latest research, 'Statins Market to 2018 - Weak Product Pipeline and Shift of Focus towards Combination Therapies will Lead to Erosion of Brand Share”, which provides insights into the glob... mehr

Healthcare, Regulatory and Reimbursement Landscape - Denmark


Summary


GlobalData, the industry analysis specialist, has released its new report, 'Healthcare, Regulatory and Reimbursement Landscape - Denmark”. The report is an essential source of information and analysis on Denmark`s healthcare, regulatory and reimbursement landscape. It identifies the key trends in the healthcare market and provides in... mehr

Healthcare, Regulatory and Reimbursement Landscape - Israel


Summary


GlobalData, the industry analysis specialist, has released its latest report, 'Healthcare, Regulatory and Reimbursement Landscape - Israel”. An essential source of information and analysis on the Israeli healthcare, regulatory and reimbursement landscape, it identifies the key trends in the healthcare market and provides insights into... mehr

Healthcare, Regulatory and Reimbursement Landscape - South Africa


Summary


GlobalData, the industry analysis specialist, has released its new report, 'Healthcare, Regulatory and Reimbursement Landscape - South Africa”. An essential source of information and analysis on the South African healthcare, regulatory and reimbursement landscape, this report identifies the key trends in the healthcare market, a... mehr

Healthcare, Regulatory and Reimbursement Landscape - Venezuela


Summary


GlobalData, the industry analysis specialist, has released its new report, 'Healthcare, Regulatory and Reimbursement Landscape - Venezuela”. The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape of Venezuela. The report identifies the key trends in the healthcare mar... mehr

Partnerships, Licensing, Investments and M&A Deals and Trends For November 2012 In Pharmaceuticals


Summary


GlobalData's 'Partnerships, Licensing, Investments and M&A Deals and Trends For November 2012 In Pharmaceuticals” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The re... mehr

Euromonitor International examines the strategies shaping the consumer health industry in 2012 and beyond. Included is an in-depth breakdown of the macro trends driving success and failure in the industry, and how the top companies and brands are reacting, in order to best position themselves for long-term growth. This briefing also includes in-depth analyses of the mergers and acquisitions market, the evolving regulatory landscape, and... mehr

Healthcare, Regulatory and Reimbursement Landscape - Morocco


Summary


GlobalData, the industry analysis specialist, has released its latest report, 'Healthcare, Regulatory and Reimbursement Landscape - Morocco”. An essential source of information and analysis on the Moroccan healthcare, regulatory and reimbursement landscape, this report identifies the key trends in the Morocco healthcare market, as we... mehr

Healthcare, Regulatory and Reimbursement Landscape - Nigeria


Summary


GlobalData, the industry analysis specialist, has released its new report, 'Healthcare, Regulatory and Reimbursement Landscape - Nigeria”. An essential source of information and analysis on the Nigerian healthcare, regulatory and reimbursement landscape, this report identifies the key trends in the healthcare market, as well as provi... mehr

Healthcare, Regulatory and Reimbursement Landscape - The Netherlands


Summary


GlobalData, the industry analysis specialist, has released its new report, 'Healthcare, Regulatory and Reimbursement Landscape - The Netherlands”. The report is an essential source of information and analysis regarding the healthcare, regulatory, and reimbursement landscape in the Netherlands. It identifies key trends in the ... mehr

Healthcare, Regulatory and Reimbursement Landscape - Turkey


Summary


GlobalData, the industry analysis specialist, has released its latest report, 'Healthcare, Regulatory and Reimbursement Landscape - Turkey”. It is an essential source of information and analysis on Turkey’s healthcare, regulatory and reimbursement landscape. It identifies the key trends in the healthcare market and provides insights... mehr

Healthcare, Regulatory and Reimbursement Landscape - United Arab Emirates


Summary


GlobalData, the industry analysis specialist, has released its new report, 'Healthcare, Regulatory and Reimbursement Landscape - United Arab Emirates”. An essential source of information and analysis on the Polish healthcare, regulatory and reimbursement landscape, this report identifies the key trends in the healthcare ... mehr

In 2012, consumer health registered stronger value growth compared to the CAGR seen over the review period. Improved economic conditions in Azerbaijan are amongst the most important reasons for growth. Consumers remain value-orientated, seeking the best price for higher quality and safe products. Rising urbanisation is a very important factor for growth as the consumption of a number of products, such as cough, cold and allergy remedies... mehr

Healthcare, Regulatory and Reimbursement Landscape - Saudi Arabia


Summary


GlobalData, the industry analysis specialist, has released its new report, 'Healthcare, Regulatory and Reimbursement Landscape - Saudi Arabia”. An essential source of information and analysis on the Saudi Arabian healthcare, regulatory, and reimbursement landscape, this report identifies the key trends in the healthcare market, ... mehr

Partnerships, Licensing, Investments and M&A Deals and Trends For September 2012 In Pharmaceuticals


Summary


GlobalData's 'Partnerships, Licensing, Investments and M&A Deals and Trends For September 2012 In Pharmaceuticals” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The ... mehr

Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q3 2012


Summary


GlobalData's 'Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q3 2012” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&A) and financing in the pharmaceutical and healthcare market. The report p... mehr

Accelerating Drugs to Market - Despite Challenges, Adaptive Clinical Trials Reduce Drug Development Costs and Time to Market


Summary


GBI Research’s new report, 'Accelerating Drugs to Market - Despite Challenges, Adaptive Clinical Trials Reduce Drug Development Costs and Time to Market”, presents various tools and strategies which can accelerate a drug to the market. In this report, GBI Research has ... mehr

Engaging Key Opinion Leaders (KOLs) - Identifying and Leveraging New KOL Groups to Drive Medical Marketing Strategy


Summary


GBI Research, the leading business intelligence provider, has released its latest research, 'Engaging Key Opinion Leaders (KOLs) - Identifying and Leveraging New KOL Groups to Drive Medical Marketing Strategy”. This report examines the roles of Key Opinion Leaders (KOLs) within t... mehr

Partnerships, Licensing, Investments and M&A Deals and Trends For August 2012 In Pharmaceuticals


Summary


GlobalData's 'Partnerships, Licensing, Investments and M&A Deals and Trends For August 2012 In Pharmaceuticals” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report... mehr

Pharmaceutical Pricing and Reimbursement - Adoption of Health Technology Assessments (HTA) Optimizes Drug Pricing and Accelerates Reimbursement Decision-Making


Summary


GBI Research, leading business intelligence provider has released its latest research report, entitled 'Pharmaceutical Pricing and Reimbursement - Adoption of Health Technology Assessments (HTA) Optimizes Drug Pricing and Accelerates Reim... mehr

Partnerships, Licensing, Investments and M&A Deals andTrends for July 2012 in Pharmaceuticals


Summary


GlobalData's 'Partnerships, Licensing, Investments and M&A Deals andTrends for July 2012 in Pharmaceuticals” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provi... mehr

Partnerships, Licensing, Investments and M&A Deals andTrends in Pharmaceuticals - Q2 2012


Summary


GlobalData's 'Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals — Q2 2012” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&A) and financing in the pharmaceutical and healthcare market. The rep... mehr

TechNavio's analysts forecast the Pharmaceutical market in Vietnam to grow at a CAGR of 18.5 percent over the period 2011-2015. One of the key factors contributing to this market growth is the increasing prevalence of diseases. The Pharmaceutical market in Vietnam has also been witnessing the trend of an increase in the number of awareness campaigns. However, poor regulatory standards in healthcare in Vietnam could pose a challenge to t... mehr

Pharmaceutical Supply Chain in Japan - Periodic Drug Price Revisions by National Health Insurance Increase Competition and Squeeze Profit Margins


Summary


Leading business intelligence provider GBI Research has released its latest research report, entitled 'Pharmaceutical Supply Chain in Japan - Periodic Drug Price Revisions by National Health Insurance Increase Competition and Squeeze Profit Margins”.... mehr

TechNavio's analysts forecast the Pharmaceuticals market in Turkey to grow at a CAGR of 14.5 percent over the period 2011-2015. One of the key factors contributing to this market growth is the adoption of the Healthcare Transformation Program in Turkey. The Pharmaceuticals market in Turkey has also been witnessing the entry of foreign players. However, the low per capita spending on healthcare could pose a challenge to the growth of thi... mehr

Retail Clinics - 2012 Yearbook


Summary


GBI Research’s new report, 'Retail Clinics - 2012 Yearbook”, provides insights into the US retail clinic market, with coverage of the market landscape, key market trends, market drivers and restraints. The report provides market forecasts for the retail clinic industry until 2018 and the distribution of the retail clinics across the US. The key stakeholders and... mehr

Biobetters in Key Markets - Opportunities for Biotechnology Companies to Sustain Innovation with Low Risk and High Value Offerings


Summary


GBI Research, the leading business intelligence provider, has released its latest research on, 'Biobetters in Key Markets - Opportunities for Biotechnology Companies to Sustain Innovation with Low Risk and High Value Offerings”, which provides insights into the imp... mehr

Direct to Consumer (DTC) Advertising in Pharmaceuticals - Shift from Traditional Mass-Media Platforms towards Personalization via Online and Social Media


Summary


GBI Research, the leading business intelligence provider, has released its latest research, 'Direct to Consumer (DTC) Advertising in Pharmaceuticals - Shift from Traditional Mass-Media Platforms towards Personalization via Online and Social Med... mehr

Emerging Pharmaceutical Market in Brazil - Regulatory Framework Forces MNCs to Partner with Local Players Resulting in Profit and Control Sharing


Summary


GBI Research’s new report, 'Emerging Pharmaceutical Market in Brazil - Regulatory Framework Forces MNCs to Partner with Local Players Resulting in Profit and Control Sharing” provides an in-depth analysis of the trends, issues and challenges in the... mehr

Partnerships, Licensing, Investments and M&A Deals and Trends for June 2012 in Pharmaceuticals


Summary


GlobalData's 'Partnerships, Licensing, Investments and M&A Deals and Trends for June 2012 in Pharmaceuticals” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report pro... mehr

Sales Force Effectiveness in Pharmaceuticals - Targeted Sales Models such as Enhanced Key Account Management (KAM) and Closed-Loop Marketing (CLM) Strategies Drives Sales Force Efficiency


Summary


Leading business intelligence provider GBI Research has released its latest research report, entitled 'Sales Force Effectiveness in Pharmaceuticals - Targeted Sales Models such as Enhanced Key Account Managemen... mehr

Biological Strategies in the Emerging Markets - BRIC Countries Will Underpin Future Pharma Growth


Summary


GBI Research, a leading business intelligence provider, has released its latest research 'Biological Strategies in the Emerging Markets - BRIC Countries Will Underpin Future Pharma Growth” which examines two major trends already impacting on marketing strategies in the global pharmaceutical enviro... mehr

Consumer health is flourishing under the influence of key demographic, regulatory, public health and corporate trends. Ageing populations offer a growing customer base, as does widespread urbanisation in developing markets. More regulatory oversight is spurring innovation and bolstering consumer confidence in self-care. Government and commercial wellness campaigns are also educating consumers. Companies are exploring regional and portfo... mehr

Emerging Pharmaceutical Market in Argentina - Domestic Pharmaceutical Companies Dominate the Market with More Than 55% of the Industry Revenue


Summary


GBI Research’s new report, 'Emerging Pharmaceutical Market in Argentina - Domestic Pharmaceutical Companies Dominate the Market with More Than 55% of the Industry Revenue” provides in-depth analysis of trends, issues and challenges in the pharmaceutic... mehr

Emerging Pharmaceutical Market in Indonesia and Philippines - 100% Foreign Direct Investment (FDI) in Indonesia and Extensive Insurance Coverage in the Philippines Attract Foreign Pharma Companies


Summary


GBI Research’s new report, 'Emerging Pharmaceutical Market in Indonesia and Philippines - 100% Foreign Direct Investment (FDI) in Indonesia and Extensive Insurance Coverage in the Philippines Attract... mehr

Emerging Pharmaceutical Market in South Africa - Proposed Introduction of New Drug Regulatory Agency (SAHPRA) to Accelerate Drug Registration Process


Summary


GBI Research’s new report, 'Emerging Pharmaceutical Market in South Africa - Proposed Introduction of New Drug Regulatory Agency (SAHPRA) to Accelerate Drug Registration Process” provides in-depth analysis of the trends, issues and challenges... mehr

Healthcare, Regulatory and Reimbursement Landscape - Philippines


Summary


GlobalData, the industry analysis specialist, has released its new report, 'Healthcare, Regulatory and Reimbursement Landscape - Philippines”. The report is an essential source of information and an analysis on the healthcare, regulatory and reimbursement landscape of Philippines. The report identifies the key trends in the healt... mehr

Partnerships, Licensing, Investments and M&A Deals and Trends for May 2012 in Pharmaceuticals


Summary


GlobalData's 'Partnerships, Licensing, Investments and M&A Deals and Trends for May 2012 in Pharmaceuticals” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provi... mehr

Pharmaceutical Pricing and Reimbursement in China - Series of Mandated Price Cuts Not Effective in Stemming Healthcare Expenditures


Summary


GBI Research, the leading business intelligence provider, has released its latest research 'Pharmaceutical Pricing and Reimbursement in China - Series of Mandated Price Cuts Not Effective in Stemming Healthcare Expenditures”. The report provides a comprehensive ov... mehr

Re-evaluating Pharmaceutical Pipelines - Emerging Markets, Biologics and Orphan Drugs to Shape Future Decision Making


Summary


GBI Research, a leading business intelligence provider, has released its latest research, 'Re-evaluating Pharmaceutical Pipelines - Emerging Markets, Biologics and Orphan Drugs to Shape Future Decision Making”, which examines the key issues influencing the re-evaluation of phar... mehr

Introduction

The pharmaceuticals market was worth $733bn in 2010. The top four market players (Pfizer Limited, Merck & Co., AstraZeneca, and GlaxoSmithKline) had a market share of 22.3%. Pfizer has been involved in many mergers and acquisitions. With some of these acquisitions came the rights to blockbuster drugs such as Lipitor (produced by Warner-Lambert) and Prevnar (produced by Wyeth).

Features and benefits... mehr

Translational Regenerative Medicine - Oncology, CNS and Cardiovascular-Rich Pipeline Features Innovative Stem Cell and Gene Therapy Applications


Summary


GBI Research, the leading business intelligence provider, has released its latest research, 'Translational Regenerative Medicine - Oncology, CNS and Cardiovascular-Rich Pipeline Features Innovative Stem Cell and Gene Therapy Applications”, which provi... mehr

Workforce Reductions in Pharmaceuticals - Outsourcing, External Innovation and Collaboration Will Drive the Industry Forward


Summary


GBI Research, the leading business intelligence provider, has released its latest research, 'Workforce Reductions in Pharmaceuticals - Outsourcing, External Innovation and Collaboration Will Drive the Industry Forward”. Job losses within the pharmaceutical industry are a... mehr

Congress on Track to Overcome Partisan Gridlock and Keep the FDA Afloat


Summary


GlobalData's analysis alert 'Congress on Track to Overcome Partisan Gridlock and Keep the FDA Afloat' analyzes legislation recently passed by the United States Senate updating the Prescription Drug User Fee Act (PDUFA) and related provisions, which are set to expire at the end of September. Congress is locked in a pitched pa... mehr

Drug Price Cuts in Top Five Countries of Europe - Tougher Reference Pricing Environment and Drug Price Freeze through 2013 Expected to Drive Down Healthcare Costs


Summary


GBI Research, the leading business intelligence provider, has released its latest research 'Drug Price Cuts in Top Five Countries of Europe - Tougher Reference Pricing Environment and Drug Price Freeze through 2013 Expected to Drive Do... mehr

Healthcare, Regulatory and Reimbursement Landscape - Indonesia


Summary


GlobalData, the industry analysis specialist, has released its new report, 'Healthcare, Regulatory and Reimbursement Landscape - Indonesia”. The report is an essential source of information and analysis, and identifies the key trends in Indonesia’s healthcare market. It also provides an insight into the demographic, regulatory, a... mehr

Studie - 'Healthness'

mehr

Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q1 2012


Summary


GlobalData's 'Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q1 2012” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&A) and financing in the pharmaceutical and healthcare market. The report p... mehr

Partnerships, Licensing, Investments and M&A Deals andTrends for April 2012 in Pharmaceuticals


Summary


GlobalData's 'Partnerships, Licensing, Investments and M&A Deals andTrends for April 2012 in Pharmaceuticals” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report pro... mehr

Patient Perspectives - Patient Reported Outcomes Drive Drug Development, but Improving Patient Involvement Remains a Challenge


Summary


GBI Research, the leading business intelligence provider, has released its latest research, 'Patient Perspectives - Patient Reported Outcomes Drive Drug Development, but Improving Patient Involvement Remains a Challenge”. The report examines the role of patients in cha... mehr

Pharmaceuticals: Global Industry Almanac is an essential resource for top-level data and analysis covering the Pharmaceuticals industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the leading companies. This incisive report provides expert analysis on a global, regional and country basis.

Scope of the Report

* Contains an... mehr

Pricing and Reimbursement in Brazil - Health Technology Assessment (HTA) Studies to Facilitate Setting of Ceiling Prices for New Drugs


Summary


GBI Research, the leading business intelligence provider, has released its latest research, 'Pricing and Reimbursement in Brazil - Health Technology Assessment (HTA) Studies to Facilitate Setting of Ceiling Prices for New Drugs”. It provides a comprehensive ove... mehr

Dietary supplements are a key area of growth in the consumer health market. Companies are reaping the financial rewards of consumer interest in preventative health through the launch of a wider array of novel and affordable supplements. Positioning dietary supplements requires negotiating a complex labyrinth of health claims, local preferences and regulatory activity. An effective message regarding health benefits, and the localisation ... mehr

Contract Manufacturing Organizations to 2018 - Cost Advantages and Improving Quality Standards Build Confidence and Encourage Foreign Investment in Asian CMOs


Summary


GBI Research, the leading business intelligence provider, has released its latest report, 'Contract Manufacturing Organizations to 2018 - Cost Advantages and Improving Quality Standards Build Confidence and Encourage Foreign Investment in ... mehr

Contract Research Organizations (CROs) Market to 2018 - Public-Private Partnerships to Strengthen Research Capacities and Advance Clinical Development Programs


Summary


GBI Research, the leading business intelligence provider, has released its latest report, 'Contract Research Organizations (CROs) Market to 2018 - Public-Private Partnerships to Strengthen Research Capacities and Advance Clinical Developm... mehr

Consumer health innovation is thriving, for example with novel and convenient delivery formats that integrate into consumers' fast-paced lifestyles. Global demographic shifts are driving demand for targeted products, and emerging markets are the source of many new offerings. Vitamins and dietary supplements, as well as formulations including herbal/traditional ingredients, are popular across all regions. Established products are explori... mehr

Partnerships, Licensing, Investments and M&A Deals and Trends for March 2012 in Pharmaceuticals


Summary


GlobalData's 'Partnerships, Licensing, Investments and M&A Deals and Trends for March 2012 in Pharmaceuticals” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report p... mehr

Pricing and Reimbursement in Generics - European Austerity Measures and Healthcare Cost Containment Puts Innovation-Driven Pharma Companies under Pressure


Summary


GBI Research, the leading business intelligence provider, has released its latest research 'Pricing and Reimbursement in Generics - European Austerity Measures and Healthcare Cost Containment Puts Innovation-Driven Pharma Companies under Press... mehr

Pricing and Reimbursement in Russia - Big Pharma Take Advantage of Reimbursement for Costly Drugs through the DLO’s Seven Nosologies Program


Summary


GBI Research, the leading business intelligence provider, has released its latest research 'Pricing and Reimbursement in Russia - Big Pharma Take Advantage of Reimbursement for Costly Drugs Through the DLO’s Seven Nosologies Program”. It provides a co... mehr

Synopsis
• This report is the result of an extensive survey drawn from ICD Research’s exclusive panel of leading pharmaceutical industry executives. The opinions and forward looking statements of 247 industry executives have been captured in our in-depth survey.

• The geographical scope of the research is global - drawing on the activity and expectations of leading industry players across the Americas, Europe, Asia... mehr

Synopsis
• This report is the result of an extensive survey drawn from ICD Research’s exclusive panel of leading pharmaceutical industry executives. The opinions and forward looking statements of 247 industry executives have been captured in our in-depth survey.

• The research is based on primary survey research conducted by ICD Research accessing its B2B panels comprised of senior marketing decision makers and lea... mehr

Healthcare, Regulatory and Reimbursement Landscape - Singapore


Summary


GlobalData, the industry analysis specialist, has released its report, 'Healthcare, Regulatory and Reimbursement Landscape - Singapore”. The report is an essential source of information and an analysis on the healthcare, regulatory and reimbursement landscape of Singapore. The report identifies the key trends in the healthcare mark... mehr

Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - March 2012


Summary


GlobalData's 'Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - March 2012” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provi... mehr

Pricing and Reimbursement of the Healthcare System in India - Low Levels of Drug Reimbursement Lead to a High Out-Of-Pocket Expenditure


Summary


GBI Research, the leading business intelligence provider, has released its latest research 'Pricing and Reimbursement of the Healthcare System in India - Low Levels of Drug Reimbursement Lead to a High Out-Of-Pocket Expenditure”. It provides a comprehensive ov... mehr

Asia Pacific continues to deliver a wealth of growth prospects for consumer health companies and organisations. A large consumer base and untapped demand for self-care options create significant expansion opportunities for domestic, regional and multinational companies. However, regulatory hurdles, patent litigation and east versus west cultural differences pose important challenges to gaining access to the largest region in the world.<... mehr

Tensions Rising between Branded Drugmakers and Health Plans


Summary


GlobalData's new alert 'Tensions Rising between Branded Drugmakers and Health Plans' analyzes the Co-Pay Coupon lawsuit and the implications for branded drugmakers and health plan providers. Large pharmaceutical companies are in the midst of a wave of patent expirations that is threatening their profitability. As drugmakers face numerou... mehr

Euromonitor International examines the companies, brands and strategies that shaped the consumer health industry in 2011. This corporate strategies briefing will also highlight the issues facing the industry in the near future, examine the industry's reactions and preparedness, and highlight examples of successful and unsuccessful tactics for dealing with an evolving marketplace.

Euromonitor International’s Corporate Strate... mehr

Emerging Pharmaceutical Market - Czech Republic - Planned Healthcare Reform Plans Forecast to Slow Growth Rates


Summary


GBI Research’s new report, 'Emerging Pharmaceutical Market - Czech Republic - Planned Healthcare Reform Plans Forecast to Slow Growth Rates” provides in-depth analysis of trends, issues and challenges in the pharmaceutical market in the Czech Republic. The report analyzes overall p... mehr

Healthcare Providers - BRIC (Brazil, Russia, India, China) Industry Guide is an essential resource for top-level data and analysis covering the BRIC (Brazil, Russia, India, China) Healthcare Providers industry. The report includes easily comparable data on market value, volume, segmentation and market share, plus full five year market forecasts. It examines future problems, innovations and potential growth areas within the market.
... mehr

Healthcare Providers - Global Group of Eight (G8) Industry Guide is an essential resource for top-level data and analysis covering the Healthcare Providers industry in each of the G8 (United States, Canada, Germany, France, United Kingdom, Italy, Russia and Japan) countries. The report includes easily comparable data on market value, volume, segmentation and market share, plus full five year market forecasts. It examines future problems... mehr

Healthcare Providers - North America (NAFTA) Industry Guide is an essential resource for top-level data and analysis covering the Healthcare Providers industry in each of the North American Free Trade Agreement (United States, Canada, and Mexico) countries. The report includes easily comparable data on market value, volume, segmentation and market share, plus full five year market forecasts. It examines future problems, innovations and ... mehr

Healthcare Providers - Scandinavia Industry Guide is an essential resource for top-level data and analysis covering the Healthcare Providers industry in each of the Scandinavian (Denmark, Norway and Sweden) countries. The report includes easily comparable data on market value, segmentation, and five forces analysis, plus full five year market forecasts for each country. It examines future problems, innovations and potential growth areas... mehr

Healthcare Providers - Top 5 Emerging Markets Industry Guide is an essential resource for top-level data and analysis covering the Healthcare Providers industry in each of the Top 5 Emerging markets (Brazil, China, India, Mexico and South Africa). The report includes easily comparable data on market value, volume, segmentation and market share, plus full five year market forecasts. It examines future problems, innovations and potential ... mehr

Healthcare Providers: Global Industry Almanac is an essential resource for top-level data and analysis covering the Healthcare Providers industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the leading companies. This incisive report provides expert analysis on a global, regional and country basis.

Scope of the Report

* C... mehr

Healthcare Providers: Global Industry Guide is an essential resource for top-level data and analysis covering the Healthcare Providers industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the leading companies. This incisive report provides expert analysis on a global, regional and country basis.

Scope of the Report

* Con... mehr

Healthcare, Regulatory and Reimbursement Landscape - Brazil


Summary


GlobalData, the industry analysis specialist, has released its new report, 'Healthcare, Regulatory and Reimbursement Landscape - Brazil”. The report is an essential source of information and analysis on Brazil’s healthcare, regulatory and reimbursement landscape, and identifies the key trends in the healthcare market. The report als... mehr

Healthcare, Regulatory and Reimbursement Landscape - China


Summary


GlobalData, Industry analysis specialist, has released its new report, 'Healthcare, Regulatory and Reimbursement Landscape - China”. The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape of China. The report identifies the key trends in the Chinese healthcare market, as ... mehr

Impact of Eurozone Crisis on Healthcare Economics


Summary


GlobalData, the industry analysis specialist, has released its new report, 'Impact of Eurozone Crisis on Healthcare Economics”. The report is an essential source of information for the analysis on the impact of the Eurozone crisis on the healthcare economics. The report reviews various measures employed in the healthcare sector in order to aver... mehr

Pricing and Reimbursement in the US - Non-LIS Beneficiaries Not Covered by Medicare Coverage Gap to Gain from Reduction in Out-of-Pocket Expenditure for Generic Drugs

Summary

GBI Research, the leading business intelligence provider, has released its latest research 'Pricing and Reimbursement in the US - Non-LIS Beneficiaries Not Covered by Medicare Coverage Gap to Gain from Reduction in Out-of-Pocket Expenditure fo... mehr

Rapid Tests and Point of Care Market to 2017 - Clinical Chemistry Tests to be the Major Revenue Generator

Summary

GBI Research’s report, 'Rapid Tests and Point of Care Market to 2017 - Clinical Chemistry Tests to be the Major Revenue Generator”, provides key data, information and analysis on the global rapid tests and point of care (POC) market. The report provides information on the market landscape, the compe... mehr

Pharmaceuticals - North America (NAFTA) Industry Guide is an essential resource for top-level data and analysis covering the Pharmaceuticals industry in each of the North American Free Trade Agreement (United States, Canada, and Mexico) countries. The report includes easily comparable data on market value, volume, segmentation and market share, plus full five year market forecasts. It examines future problems, innovations and potential ... mehr

Pharmaceuticals - Scandinavia Industry Guide is an essential resource for top-level data and analysis covering the Pharmaceuticals industry in each of the Scandinavian (Denmark, Norway and Sweden) countries. The report includes easily comparable data on market value, segmentation, and five forces analysis, plus full five year market forecasts for each country. It examines future problems, innovations and potential growth areas within th... mehr

Pharmaceuticals - Top 5 Emerging Markets Industry Guide is an essential resource for top-level data and analysis covering the Pharmaceuticals industry in each of the Top 5 Emerging markets (Brazil, China, India, Mexico and South Africa). The report includes easily comparable data on market value, volume, segmentation and market share, plus full five year market forecasts. It examines future problems, innovations and potential growth are... mehr

Pharmaceuticals: Global Industry Guide is an essential resource for top-level data and analysis covering the Pharmaceuticals industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the leading companies. This incisive report provides expert analysis on a global, regional and country basis.

Scope of the Report

* Contains an e... mehr

Licensing Activity In Pharmaceutical & Healthcare Industry - Q3 2011

Summary

GlobalData's 'Licensing Activity In Pharmaceutical & Healthcare Industry - Q3 2011” report is an essential source of data and trend analysis on licensing agreements in the pharmaceuticals industry. The report provides detailed information on licensing transactions registered in the pharmaceuticals industry in Q3 2011. The report ... mehr

Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - December 2011

Summary

GlobalData's 'Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - December 2011” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides de... mehr

Cross-Border M&A Activity In Pharmaceutical & Healthcare Industry - Q3 2011

Summary

GlobalData's 'Cross-Border M&A Activity In Pharmaceutical & Healthcare Industry - Q3 2011” report is an essential source of data and trend analysis on cross border mergers and acquisitions (M&As) and asset transactions in the pharmaceuticals industry. The report provides detailed information on cross border and... mehr

Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - November 2011

Summary

GlobalData's 'Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - November 2011” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides de... mehr

Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q3 2011

Summary

GlobalData's 'Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q3 2011” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&A) and financing in the pharmaceutical and healthcare market. The report provides deta... mehr

Pharmaceutical Pricing and Reimbursement in Europe - Reference Pricing and Similar Initiatives Being Applied to Innovative Drugs Pose Significant Challenge to Pharmaceutical Companies

Summary

GBI Research, the leading business intelligence provider, has released its latest research 'Pharmaceutical Pricing and Reimbursement in Europe - Reference Pricing and Similar Initiatives Being Applied to Innovative Drugs Pose ... mehr

Synopsis
• The report is based on primary surveys conducted by ICD Research accessing its B2B panels comprised of senior business decision makers. The opinions and forward looking statements on sustainability management of 287 industry executives are captured in our in-depth survey, of which 44% represent directors, C-level executives and departmental heads.

• The geographical scope of the research is global — ... mehr

Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - October 2011

Summary

GlobalData's 'Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - October 2011” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides deta... mehr

Blood Disorders Therapeutics Market to 2017 - Patent Expiries of Lovenox, Plavix, Procrit/Epogen, Aranesp and Neulasta Will Slow Down Growth

Summary

GBI Research, the leading business intelligence provider, has released its latest research 'Blood Disorders Therapeutics Market to 2017 - Patent Expiries of Lovenox, Plavix, Procrit/Epogen, Aranesp and Neulasta Will Slow Down Growth”. The report provides in-depth ana... mehr

Coagulation Disorders Market to 2017 - Hemophilia A, the Largest Segment, to Witness a Decline in Growth Rate due to Patent Expiries and Weak Pipeline

Summary

GBI Research, the leading business intelligence provider, has released its latest research, 'Coagulation Disorders Market to 2017 - Hemophilia A, the Largest Segment, to Witness a Decline in Growth Rate due to Patent Expiries and Weak Pipeline”, provides in... mehr

Critical Care Market to 2017 - Shift of Focus towards PCC, Factor Concentrates and Antithrombins due to Better Safety and Efficacy Profiles

Summary

GBI Research's report, 'Critical Care Market to 2017 - Shift of Focus towards PCC, Factor Concentrates and Antithrombins due to Better Safety and Efficacy Profiles” provides in-depth analysis of drivers and barriers that impact the global critical care market. The rep... mehr

Emerging Pharmaceutical Market in China - Forecast to Become The World’s Third-Largest Pharmaceutical Market By 2013

Summary

GBI Research’s new report, 'Emerging Pharmaceutical Market in China - Forecast to Become The World’s Third-Largest Pharmaceutical Market By 2013”, provides in-depth analysis of trends, issues and challenges in this industry. The report analyzes the effective strategies that shape the ... mehr

Immunoglobulins Market to 2017 - Off-Label Usage and Treatment of Primary Immunodeficiency Diseases and Neurological Disorders Stimulate Market Growth

Summary

GBI Research’s report, 'Immunoglobulins Market to 2017 - Off-Label Usage and Treatment of Primary Immunodeficiency Diseases and Neurological Disorders Stimulate Market Growth” provides in-depth analysis of the, drivers and barriers that affect the global ... mehr

Innovative R&D Strategies and Models - Outsourcing, Strategic Partnerships and Licensing to Improve Productivity and Contain Costs

Summary

GBI Research has released its latest research 'Innovative R&D Strategies and Models - Outsourcing, Strategic Partnerships and Licensing to Improve Productivity and Contain Costs”, which provides insights into effective innovative strategies adopted by the pharmaceutica... mehr

Licensing Strategies of Large Pharmaceutical Companies - Weak R&D Pipelines and the Patent Cliff Stimulate In-Licensing Activity

Summary

GBI Research has released its latest research, 'Licensing Strategies of Large Pharmaceutical Companies - Weak R&D Pipelines and the Patent Cliff Stimulate In-Licensing Activity” which provides insights into the licensing agreements of large pharmaceutical companies. The ... mehr

Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - September 2011

Summary

GlobalData's 'Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - September 2011” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides ... mehr

Pharmaceutical Partnership Deal Terminations

Summary

GBI Research, the leading business intelligence provider, has released its latest report, 'Pharmaceutical Partnership Deal Terminations” which provides key data, information and analysis of the major deals terminated in pharma industry in the period January, 2010, to June, 2011. The report provides a comprehensive insight into the partner companies involved in ... mehr

Post Marketing Clinical Research - REMS, the Latest Reformation due to Post Marketing Surveillance to Enhance Patient Compliance

Summary

GBI Research has released its latest report, 'Post Marketing Clinical Research - REMS, the Latest Reformation due to Post Marketing Surveillance to Enhance Patient Compliance” that provides key data, information and analysis of the major trends and developments in post marketing... mehr

Therapeutic Proteins Market to 2017 - High Demand for Monoclonal Antibodies will Drive the Market

Summary

GBI Research, the leading business intelligence provider, has released its latest research, 'Therapeutic Proteins Market to 2017 - High Demand for Monoclonal Antibodies will Drive the Market”, which provides insights regarding therapeutic proteins sales forecasts until 2017. Therapeutic proteins markets in th... mehr

Adult and Adolescent Vaccines Market to 2017 - Partnerships Increase as Licensing and Co-Development Account for 73% of all Deal-Making Activity in 2010

Summary

GBI Research, the leading business intelligence provider, has released its latest research, 'Adult and Adolescent Vaccines Market to 2017 - Partnerships Increase as Licensing and Co-Development Account for 73% of all Deal-Making Activity in 2010”, which p... mehr

Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q2 2011

Summary

GlobalData's 'Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q2 2011” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&A) and financing in the pharmaceutical and healthcare market. The report provides deta... mehr

71st Scientific sessions of American Diabetes Association 2011 - Post-Conference Review and Analysis

Summary

GlobalData, the industry analysis specialist, has released its new conference alerts, '71st Scientific sessions of American Diabetes Association 2011 - Post-Conference Review and Analysis”. The conference alert is an essential source of information and analysis on the emerging therapies and new disease man... mehr

AlphaVax, Inc. — Product Pipeline Review — Q2 2011

Summary

Global Market Direct’s pharmaceuticals report, 'AlphaVax, Inc. - Product Pipeline Review - Q2 2011” provides data on the AlphaVax, Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report... mehr

Aquinox Pharmaceuticals Inc. — Product Pipeline Review — Q2 2011

Summary

Global Market Direct’s pharmaceuticals report, 'Aquinox Pharmaceuticals Inc. - Product Pipeline Review - Q2 2011” provides data on the Aquinox Pharmaceuticals Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and... mehr

AVEO Pharmaceuticals, Inc. — Product Pipeline Review — Q2 2011

Summary

Global Market Direct’s pharmaceuticals report, 'AVEO Pharmaceuticals, Inc. - Product Pipeline Review - Q2 2011” provides data on the AVEO Pharmaceuticals, Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dorma... mehr

Basilea Pharmaceutica Ltd. — Product Pipeline Review — Q2 2011

Summary

Global Market Direct’s pharmaceuticals report, 'Basilea Pharmaceutica Ltd. - Product Pipeline Review - Q2 2011” provides data on the Basilea Pharmaceutica Ltd.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dorma... mehr

Bavarian Nordic A/S — Product Pipeline Review — Q2 2011

Summary

Global Market Direct’s pharmaceuticals report, 'Bavarian Nordic A/S - Product Pipeline Review - Q2 2011” provides data on the Bavarian Nordic A/S’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
mehr

Celltrion, Inc. — Product Pipeline Review — Q2 2011

Summary

Global Market Direct’s pharmaceuticals report, 'Celltrion, Inc. - Product Pipeline Review - Q2 2011” provides data on the Celltrion, Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This rep... mehr

Compugen Ltd. — Product Pipeline Review — Q2 2011

Summary

Global Market Direct’s pharmaceuticals report, 'Compugen Ltd. - Product Pipeline Review - Q2 2011” provides data on the Compugen Ltd.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is... mehr

Critical Outcome Technologies Inc. — Product Pipeline Review — Q2 2011

Summary

Global Market Direct’s pharmaceuticals report, 'Critical Outcome Technologies Inc. - Product Pipeline Review - Q2 2011” provides data on the Critical Outcome Technologies Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features o... mehr

Cyclacel Pharmaceuticals Inc. — Product Pipeline Review — Q2 2011

Summary

Global Market Direct’s pharmaceuticals report, 'Cyclacel Pharmaceuticals Inc. - Product Pipeline Review - Q2 2011” provides data on the Cyclacel Pharmaceuticals Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued ... mehr

Digna Biotech, S.L. — Product Pipeline Review — Q2 2011

Summary

Global Market Direct’s pharmaceuticals report, 'Digna Biotech, S.L. - Product Pipeline Review - Q2 2011” provides data on the Digna Biotech, S.L.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
mehr

Emerging Market for Clinical Trials in Argentina - Major Cost Advantages over the US in Conducting Clinical Trials Will Encourage Drug Development

Summary

GBI Research has released its latest report, 'Emerging Market for Clinical Trials in Argentina - Major Cost Advantages over the US in Conducting Clinical Trials Will Encourage Drug Development” that provides key data, information and analysis of the major trend... mehr

Emerging Market for Clinical Trials in Brazil - Improved Guidelines from ANVISA and CONEP are Shortening the Regulatory Approval Process and Advancing the Market

Summary

GBI Research, the leading business intelligence provider, has released its latest report, 'Emerging Market for Clinical Trials in Brazil - Improved Guidelines from ANVISA and CONEP are Shortening the Regulatory Approval Process and Advancing the Ma... mehr

Emerging Market for Clinical Trials in Russia - Curbs on New Drug Approval Timelines and Registration Fees Encourage the Emergence of a Major Global Player

Summary

GBI Research has released its latest report, 'Emerging Market for Clinical Trials in Russia - Curbs on New Drug Approval Timelines and Registration Fees Encourage the Emergence of a Major Global Player” that provides key data, information and analysis ... mehr

Endocyte, Inc. — Product Pipeline Review — Q2 2011

Summary

Global Market Direct’s pharmaceuticals report, 'Endocyte, Inc. - Product Pipeline Review - Q2 2011” provides data on the Endocyte, Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report... mehr

Eurofarma — Product Pipeline Review — Q2 2011

Summary

Global Market Direct’s pharmaceuticals report, 'Eurofarma - Product Pipeline Review - Q2 2011” provides data on the Eurofarma’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using... mehr

Five Prime Therapeutics, Inc. — Product Pipeline Review — Q2 2011

Summary

Global Market Direct’s pharmaceuticals report, 'Five Prime Therapeutics, Inc. - Product Pipeline Review - Q2 2011” provides data on the Five Prime Therapeutics, Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued ... mehr

Galapagos NV — Product Pipeline Review — Q2 2011

Summary

Global Market Direct’s pharmaceuticals report, 'Galapagos NV - Product Pipeline Review - Q2 2011” provides data on the Galapagos NV’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is bu... mehr

Genfit — Product Pipeline Review — Q2 2011

Summary

Global Market Direct’s pharmaceuticals report, 'Genfit - Product Pipeline Review - Q2 2011” provides data on the Genfit’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and... mehr

GenPhar, Inc. — Product Pipeline Review — Q2 2011

Summary

Global Market Direct’s pharmaceuticals report, 'GenPhar, Inc. - Product Pipeline Review - Q2 2011” provides data on the GenPhar, Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is... mehr

IntelGenx Corp. — Product Pipeline Review — Q2 2011

Summary

Global Market Direct’s pharmaceuticals report, 'IntelGenx Corp. - Product Pipeline Review - Q2 2011” provides data on the IntelGenx Corp.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This rep... mehr

Miraca Holdings Inc. — Product Pipeline Review — Q2 2011

Summary

Global Market Direct’s pharmaceuticals report, 'Miraca Holdings Inc. - Product Pipeline Review - Q2 2011” provides data on the Miraca Holdings Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
mehr

MorphoSys AG — Product Pipeline Review — Q2 2011

Summary

Global Market Direct’s pharmaceuticals report, 'MorphoSys AG - Product Pipeline Review - Q2 2011” provides data on the MorphoSys AG’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is bu... mehr

Myrexis, Inc. — Product Pipeline Review — Q2 2011

Summary

Global Market Direct’s pharmaceuticals report, 'Myrexis Inc - Product Pipeline Review - Q2 2011” provides data on the Myrexis Inc’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is bui... mehr

NanoBio Corporation — Product Pipeline Review — Q2 2011

Summary

Global Market Direct’s pharmaceuticals report, 'NanoBio Corporation - Product Pipeline Review - Q2 2011” provides data on the NanoBio Corporation’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
mehr

Nerviano Medical Sciences S.r.l. — Product Pipeline Review — Q2 2011

Summary

Global Market Direct’s pharmaceuticals report, 'Nerviano Medical Sciences S.r.l. - Product Pipeline Review - Q2 2011” provides data on the Nerviano Medical Sciences S.r.l.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on disc... mehr

Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals, July 2011

Summary

GlobalData's 'Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals, July 2011” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides detailed inf... mehr

Patrys Limited — Product Pipeline Review — Q2 2011

Summary

Global Market Direct’s pharmaceuticals report, 'Patrys Limited - Product Pipeline Review - Q2 2011” provides data on the Patrys Limited’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report... mehr

Peregrine Pharmaceuticals, Inc. — Product Pipeline Review — Q2 2011

Summary

Global Market Direct’s pharmaceuticals report, 'Peregrine Pharmaceuticals, Inc. - Product Pipeline Review - Q2 2011” provides data on the Peregrine Pharmaceuticals, Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discont... mehr

Pieris AG — Product Pipeline Review — Q2 2011

Summary

Global Market Direct’s pharmaceuticals report, 'Pieris AG - Product Pipeline Review - Q2 2011” provides data on the Pieris AG’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using... mehr

Stelic Institute & Co. — Product Pipeline Review — Q2 2011

Summary

Global Market Direct’s pharmaceuticals report, 'Stelic Institute & Co. - Product Pipeline Review - Q2 2011” provides data on the Stelic Institute & Co.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dorma... mehr

Stemline Therapeutics, Inc. — Product Pipeline Review — Q2 2011

Summary

Global Market Direct’s pharmaceuticals report, 'Stemline Therapeutics, Inc. - Product Pipeline Review - Q2 2011” provides data on the Stemline Therapeutics, Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and do... mehr

Summit Corporation plc — Product Pipeline Review — Q2 2011

Summary

Global Market Direct’s pharmaceuticals report, 'Summit Corporation plc - Product Pipeline Review - Q2 2011” provides data on the Summit Corporation plc’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.... mehr

Syndax Pharmaceuticals, Inc. — Product Pipeline Review — Q2 2011

Summary

Global Market Direct’s pharmaceuticals report, 'Syndax Pharmaceuticals, Inc. - Product Pipeline Review - Q2 2011” provides data on the Syndax Pharmaceuticals, Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and... mehr

Theraptosis S.A. — Product Pipeline Review — Q2 2011

Summary

Global Market Direct’s pharmaceuticals report, 'Theraptosis S.A. - Product Pipeline Review - Q2 2011” provides data on the Theraptosis S.A.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This ... mehr

VasGene Therapeutics, Inc. — Product Pipeline Review — Q2 2011

Summary

Global Market Direct’s pharmaceuticals report, 'VasGene Therapeutics, Inc. - Product Pipeline Review - Q2 2011” provides data on the VasGene Therapeutics, Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dorma... mehr

Xenon Pharmaceuticals Inc. — Product Pipeline Review — Q2 2011

Summary

Global Market Direct’s pharmaceuticals report, 'Xenon Pharmaceuticals Inc. - Product Pipeline Review - Q2 2011” provides data on the Xenon Pharmaceuticals Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dorma... mehr

Xigen SA — Product Pipeline Review — Q2 2011

Summary

Global Market Direct’s pharmaceuticals report, 'Xigen SA - Product Pipeline Review - Q2 2011” provides data on the Xigen SA’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using da... mehr

ZIOPHARM Oncology, Inc. — Product Pipeline Review — Q2 2011

Summary

Global Market Direct’s pharmaceuticals report, 'ZIOPHARM Oncology, Inc. - Product Pipeline Review - Q2 2011” provides data on the ZIOPHARM Oncology, Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projec... mehr

Bayer’s heritage lies in Aspirin, which the company developed in 1892. While new benefits continue to be found for the compound, Bayer has moved beyond the drug and become a leading player in vitamins and dietary supplements, as well as antifungals. The company continues to be overly reliant on the analgesics category, however, and sales of Aspirin have suffered with increased competition from private label alternatives, as well as ot... mehr

Bristol Myers-Squibb is primarily focused on biopharma, but retains despite a number of divestments in recent years a modest presence in consumer health. The company has a relatively fragmented portfolio of brands and a disparate geographic presence. Bristol Myers-Squibb has frequently been speculated as a potential target for acquisition and as a potential seller of its consumer health portfolio. To date, however, no announcement has b... mehr

Synopsis
This report is the result of an extensive survey drawn from ICD Research’s exclusive panel of leading pharmaceutical industry executives. It analyzes how pharmaceutical companies’ procurement expenditure, business strategies and practices are set to change in 2011—2012. This report gives you access to the category-level spending outlooks, budgets, supplier selection criteria, business challenges and investment op... mehr

Impact of Counterfeits on Pharmaceutical Industry - Counterfeiting Poses Threats to Patient Safety and Revenues of Pharmaceutical Companies

Summary

GBI Research’s report, 'Impact of Counterfeits on Pharmaceutical Industry - Counterfeiting Poses Threats to Patient Safety and Revenues of Pharmaceutical Companies”, provides in-depth analysis of trends, issues and challenges in this industry. The report analyzes th... mehr

Impact of US Healthcare Reforms - the Extension of Care to 32 Million Uninsured Citizens from 2014 and Implications for the Pharmaceutical Industry

Summary

GBI Research has released its latest report, 'Impact of US Healthcare Reforms - the Extension of Care to 32 Million Uninsured Citizens from 2014 and Implications for the Pharmaceutical Industry” that provides key data, information and analysis of the US health... mehr

Kidney and Renal Diseases Therapeutics Market to 2017 - Strong Pipeline and Unmet Need Due to Poor Safety Profiles to Create Opportunities for Growth

Summary

GBI Research’s report, 'Kidney and Renal Diseases Therapeutics Market to 2017 - Strong Pipeline and Unmet Need Due to Poor Safety Profiles to Create Opportunities for Growth”, provides in-depth analysis of unmet needs, drivers and barriers that impact the ... mehr

Lead Generation Strategies and Technologies in Drug Development - Emerging Techniques Such as Antisense Technology Will Allow Innovators to Minimize Costs

Summary

GBI Research has released its latest report, 'Lead Generation Strategies and Technologies in Drug Development - Emerging Techniques Such as Antisense Technology Will Allow Innovators to Minimize Costs” that provides key data, information and analysis of... mehr

Lifesciences IT - 2011 Yearbook

Summary

GBI Research's research, 'Lifesciences IT - 2011 Yearbook' provides key data, information and analysis on Lifesciences IT that is being implemented by pharmaceutical companies. GBI Research expects that information technology (IT) in the lifesciences industry will become a trendsetter, helping pharmaceutical companies mitigate current and evolving industry challenges. IT solu... mehr

NBTY is the leader in the VDS category in the US. The company was recently acquired and made private by private equity investor Carlyle Group. The intention of the company’s new backers will likely be international expansion, as NBTY remains overly dependent on the US market. The recent acquisition of a Chinese VDS manufacturer is indicative of the company’s global aspirations.

Euromonitor International’s NBTY Inc in C... mehr

Novartis is the fourth ranked consumer health company in the world, with total global sales of US$4.3 billion. It has enjoyed a number of achievements in 2009/2010 including the highly successful launch of Prevacid in the US market, followed by the launch of Pantoloc Control in 14 European markets. It also successfully completed the acquisition of Alcon, which gave it a much more significant presence in eye care.

Euromonitor ... mehr

Opioids Market to 2017 - Steady Uptake of Oxycontin and High Incidence Of Diseases Such As Cancer And Arthritis to Drive the Market

Summary

GBI Research, the leading business intelligence provider, has released its latest research, 'Opioids Market to 2017 - Steady Uptake of Oxycontin and High Incidence Of Diseases Such As Cancer And Arthritis to Drive the Market”, which provides insights into global opioids marke... mehr

Otsuka Holdings Co Ltd is the third largest global player in the vitamins and dietary supplements category. This company profile focuses on the company’s efforts to reduce its reliance on Japan and the US through expansion in Asia and Europe, and to develop a diverse but integrated, nutrition-based offer.

Euromonitor International’s Otsuka Holdings Co Ltd in Consumer Health (World) Company Profile offers detailed strateg... mehr

Pharmaceuticals Monthly Deal Analysis - Partnerships, Licensing, Investments and M&A Trends, June 2011

Summary

GlobalData's 'Pharmaceuticals Monthly Deal Analysis - Partnerships, Licensing, Investments and M&A Trends, June 2011” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report... mehr

The 2011 ASCO (American Society of Clinical Oncology) Annual Meeting - Post Conference Review and Analysis

Summary

GlobalData, the industry analysis specialist, has released its new conference alerts, 'The 2011 ASCO (American Society of Clinical Oncology) Annual Meeting - Post Conference Review and Analysis”. The conference alert is an essential source of information and analysis on the emerging therapies and new... mehr

The 43rd Meeting 2011 of the European Pancreatic Club — Post Conference Review and Analysis

Summary

GlobalData, the industry analysis specialist, has released its new conference alert, 'The 43rd Meeting 2011 of the European Pancreatic Club — Post Conference Review and Analysis”. The conference alert is an essential source of information and analysis on the emerging therapies and new disease management... mehr

Time and Cost Reduction in Clinical Trials- Outsourcing and IT to Optimize Patient Recruitment, Logistics, Data and Site Management

Summary

GBI Research, the leading business intelligence provider, has released its latest research, 'Time and Cost Reduction in Clinical Trials- Outsourcing and IT to Optimize Patient Recruitment, Logistics, Data and Site Management”. The report provides in-depth analysis of the majo... mehr

63rd Annual Meeting of the American Academy of Neurology - Post Conference Review and Analysis

Summary

GlobalData, the industry analysis specialist, has released its new conference alerts, '63rd Annual Meeting of the American Academy of Neurology: Review and Analysis”. The conference alert is an essential source of information and analysis on the emerging therapies and new disease management techniques.

mehr

Asia Pacific Hospital Supplies Market Outlook to 2017

Summary

GlobalData’s new report, 'Asia Pacific Hospital Supplies Market Outlook to 2017” provides key market data on the Asia-Pacific Hospital Supplies market — Australia, China, India and Japan. The report provides value (USD million) data for all the market categories — Disposable Hospital Supplies, Mobility Aids and Transportation Equipment,... mehr

The economic recovery helped consumer health maintain vigorous growth in retail value sales in 2010. Regulation has intensified in all categories, while the competitive strategy is now shifting to regional and local investment. Asia-Pacific and North America lead global sales, thanks in part to the rising popularity of vitamins and dietary supplements. An enhanced retailing atmosphere provides new sales opportunities via new health and ... mehr

Europe Hospital Supplies Market Outlook to 2017

Summary

GlobalData’s new report, 'Europe Hospital Supplies Market Outlook to 2017” provides key market data on the Europe Hospital Supplies market — France, Germany, Italy, Spain and United Kingdom. The report provides value (USD million) data for all the market categories — Disposable Hospital Supplies, Mobility Aids and Transportation Equipment, O... mehr

Generic Growth Strategies - Manufacturers to Increase Focus on Super Generics and Biosimilars to Drive Revenues

Summary

GBI Research has released its research 'Generic Growth Strategies - Manufacturers to Increase Focus on Super Generics and Biosimilars to Drive Revenues”. It provides a comprehensive overview of the generic drugs market, analysis of upcoming noteworthy patent expirations, and trends and issues fa... mehr

Hospital Supplies Market Outlook in Argentina to 2017 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others

Summary

GlobalData’s new report, 'Hospital Supplies Market Outlook in Argentina to 2017 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others” provides key market data on the Argentina Hospital Supplies... mehr

Hospital Supplies Market Outlook in Australia to 2017 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others

Summary

GlobalData’s new report, 'Hospital Supplies Market Outlook in Australia to 2017 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others” provides key market data on the Australia Hospital Supplies... mehr

Hospital Supplies Market Outlook in Austria to 2017 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others

Summary

GlobalData’s new report, 'Hospital Supplies Market Outlook in Austria to 2017 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others” provides key market data on the Austria Hospital Supplies marke... mehr

Hospital Supplies Market Outlook in Belgium to 2017 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others

Summary

GlobalData’s new report, 'Hospital Supplies Market Outlook in Belgium to 2017 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others” provides key market data on the Belgium Hospital Supplies marke... mehr

Hospital Supplies Market Outlook in Brazil to 2017 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others

Summary

GlobalData’s new report, 'Hospital Supplies Market Outlook in Brazil to 2017 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others” provides key market data on the Brazil Hospital Supplies market. ... mehr

Hospital Supplies Market Outlook in Czech Republic to 2017 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others

Summary

GlobalData’s new report, 'Hospital Supplies Market Outlook in Czech Republic to 2017 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others” provides key market data on the Czech Republic Ho... mehr

Hospital Supplies Market Outlook in Denmark to 2017 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others

Summary

GlobalData’s new report, 'Hospital Supplies Market Outlook in Denmark to 2017 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others” provides key market data on the Denmark Hospital Supplies marke... mehr

Hospital Supplies Market Outlook in Germany to 2017 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others

Summary

GlobalData’s new report, 'Hospital Supplies Market Outlook in Germany to 2017 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others” provides key market data on the Germany Hospital Supplies marke... mehr

Hospital Supplies Market Outlook in Israel to 2017 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others

Summary

GlobalData’s new report, 'Hospital Supplies Market Outlook in Israel to 2017 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others” provides key market data on the Israel Hospital Supplies market. ... mehr

Hospital Supplies Market Outlook in Italy to 2017 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others

Summary

GlobalData’s new report, 'Hospital Supplies Market Outlook in Italy to 2017 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others” provides key market data on the Italy Hospital Supplies market. The... mehr

Hospital Supplies Market Outlook in Mexico to 2017 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others

Summary

GlobalData’s new report, 'Hospital Supplies Market Outlook in Mexico to 2017 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others” provides key market data on the Mexico Hospital Supplies market. ... mehr

Hospital Supplies Market Outlook in Netherlands to 2017 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others

Summary

GlobalData’s new report, 'Hospital Supplies Market Outlook in Netherlands to 2017 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others” provides key market data on the Netherlands Hospital Su... mehr

Hospital Supplies Market Outlook in New Zealand to 2017 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others

Summary

GlobalData’s new report, 'Hospital Supplies Market Outlook in New Zealand to 2017 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others” provides key market data on the New Zealand Hospital Su... mehr

Hospital Supplies Market Outlook in Republic of Korea to 2017 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others

Summary

GlobalData’s new report, 'Hospital Supplies Market Outlook in Republic of Korea to 2017 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others” provides key market data on the Republic of... mehr

Hospital Supplies Market Outlook in Saudi Arabia to 2017 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others

Summary

GlobalData’s new report, 'Hospital Supplies Market Outlook in Saudi Arabia to 2017 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others” provides key market data on the Saudi Arabia Hospital... mehr

Hospital Supplies Market Outlook in South Africa to 2017 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others

Summary

GlobalData’s new report, 'Hospital Supplies Market Outlook in South Africa to 2017 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others” provides key market data on the South Africa Hospital... mehr

Hospital Supplies Market Outlook in Spain to 2017 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others

Summary

GlobalData’s new report, 'Hospital Supplies Market Outlook in Spain to 2017 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others” provides key market data on the Spain Hospital Supplies market. The... mehr

Hospital Supplies Market Outlook in Sweden to 2017 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others

Summary

GlobalData’s new report, 'Hospital Supplies Market Outlook in Sweden to 2017 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others” provides key market data on the Sweden Hospital Supplies market. ... mehr

Hospital Supplies Market Outlook in Taiwan to 2017 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others

Summary

GlobalData’s new report, 'Hospital Supplies Market Outlook in Taiwan to 2017 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others” provides key market data on the Taiwan Hospital Supplies market. ... mehr

Innovations in Protein Kinase Therapies - Significant Proportion of Protein Kinase Pipeline Contains Small Molecule Drugs That Target Oncology

Summary

GBI Research’s report, 'Innovations in Protein Kinase Therapies - Significant Proportion of Protein Kinase Pipeline Contains Small Molecule Drugs That Target Oncology”, provides in-depth analysis of innovations in protein kinase therapies in the current pharmaceu... mehr

Medical Equipment Monthly Deals Analysis - M&A and Investment Trends, May 2011

Summary

GlobalData's 'Medical Equipment Monthly Deals Analysis - M&A and Investment Trends, May 2011” report is an essential source of data and trend analysis on the mergers and acquisitions (M&As) and financings in the medical equipment industry. The report provides detailed information on M&As, equity/debt offerings, ... mehr

North America Hospital Supplies Market Outlook to 2017

Summary

GlobalData’s new report, 'North America Hospital Supplies Market Outlook to 2017” provides key market data on the North America Hospital Supplies market — Canada and United States. The report provides value (USD million) data for all the market categories — Disposable Hospital Supplies, Mobility Aids and Transportation Equipment, Oper... mehr

Synopsis
ICD Research’s report, Packaging Machinery in Europe to 2015: Market Guideprovides in-depth knowledge of the market trends and drivers of the Packaging Machinery market in Europe. The report includes quantitative information (historic and forecast market values, segmented at channel level) and qualitative analysis (market landscape, trends and drivers).


The report provides data, analyses and opinion to ... mehr

Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - May 2011

Summary

GlobalData's 'Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - May 2011” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides detailed inf... mehr

Synopsis
ICD Research’s report, Pharmaceutical Packaging in Asia-Pacific to 2015: Market Guideprovides in-depth knowledge of the market trends and drivers of the Pharmaceutical Packaging market in Asia-Pacific region. The report includes quantitative information (historic and forecast market values, segmented at channel level) and qualitative analysis (market landscape, trends and drivers).


The report provides d... mehr

Synopsis
ICD Research’s report, Pharmaceutical Packaging in BRIC to 2015: Market Guideprovides in-depth knowledge of the market trends and drivers of the Pharmaceutical Packaging market in BRIC region. The report includes quantitative information (historic and forecast market values, segmented at channel level) and qualitative analysis (market landscape, trends and drivers).


The report provides data, analyses an... mehr

Synopsis
ICD Research’s report, Pharmaceutical Packaging in Europe to 2015: Market Guideprovides in-depth knowledge of the market trends and drivers of the Pharmaceutical Packaging market in Europe. The report includes quantitative information (historic and forecast market values, segmented at channel level) and qualitative analysis (market landscape, trends and drivers).


The report provides data, analyses and o... mehr

Synopsis
ICD Research’s report, Rigid Plastic Packaging in Asia-Pacific to 2015: Market Guideprovides in-depth knowledge of the market trends and drivers of the Rigid Plastic Packaging market in Asia-Pacific region. The report includes quantitative information (historic and forecast market values, segmented at channel level) and qualitative analysis (market landscape, trends and drivers).


The report provides dat... mehr

Synopsis
ICD Research’s report, Rigid Plastic Packaging in BRIC to 2015: Market Guideprovides in-depth knowledge of the market trends and drivers of the Rigid Plastic Packaging market in BRIC region. The report includes quantitative information (historic and forecast market values, segmented at channel level) and qualitative analysis (market landscape, trends and drivers).


The report provides data, analyses and ... mehr

Synopsis
ICD Research’s report, Rigid Plastic Packaging in Europe to 2015: Market Guideprovides in-depth knowledge of the market trends and drivers of the Rigid Plastic Packaging market in Europe. The report includes quantitative information (historic and forecast market values, segmented at channel level) and qualitative analysis (market landscape, trends and drivers).


The report provides data, analyses and opi... mehr

Risk Evaluation and Mitigation Strategy (REMS) - Opioids, Erythropoesis-Stimulating Agents and Cancer Therapeutics are the Most Important Classes That Require REMS

Summary

GBI Research's research, 'Risk Evaluation and Mitigation Strategy (REMS) - Opioids, Erythropoesis-Stimulating Agents and Cancer Therapeutics are the Most Important Classes That Require REMS”, provides key data, information and analysis on the r... mehr

Sanofi - Aventis seals Licensing Deal with Glenmark for $613m - Deal Analysis from GlobalData

Summary

May 16, 2011 witnessed the commencement of the licensing deal between Glenmark Pharmaceuticals S.A (GPSA), a wholly owned subsidiary of Glenmark Pharmaceuticals Limited India, and Sanofi-Aventis, headquartered in Paris.

Scope

- The deal is valued at $613m and includes the upfront payment of $5... mehr

Specialty Pharmaceutical Industry - 2011 Yearbook

Summary

GBI Research's 'Specialty Pharmaceutical Industry - 2011 Yearbook” essentially provides insights on specialty pharmaceutical sales and price forecasts until 2017. The report provides in-depth therapeutics analysis of eight niche indications, namely: Human Immunodeficiency Virus (HIV)/Acquired immune deficiency syndrome (AIDS), age related macular degenerat... mehr

Technology Transfer Strategies - A Guide to Maximizing Returns Within the Pharmaceutical and Biopharmaceutical Industries

Summary

GBI Research, the leading business intelligence provider, has released its latest research, 'Technology Transfer Strategies - A Guide to Maximizing Returns Within the Pharmaceutical and Biopharmaceutical Industries”, which provides insights into global technology transfer strategies la... mehr

Biotech M&A and Licensing Strategies - Co-development Agreements are Poised to Increase in the Future to Counter Drying Pipelines

Summary

GBI Research's pharmaceutical research, 'Biotech M&A and Licensing Strategies - Co-development Agreements are Poised to Increase in the Future to Counter Drying Pipelines”, provides insights into the global biotech M&A and licensing strategies. The report provides a... mehr

Endo Pharmaceuticals to Buy American Medical Systems for $2.9 Billion - Deal Analysis from GlobalData

Summary

GlobalData’s medical equipment report, 'Endo Pharmaceuticals to Buy American Medical Systems for $2.9 Billion” provides key insights on the deal. The report provides analysis and impact on the global medical devices market as a result of the deal. This report is built using data and information sourced ... mehr

Healthcare Reform in the US - Impact on Pricing and Reimbursement

Summary

On 23 March, 2010, the Obama administration brought into effect the Patient Protection and Affordable Care Act (PPACA), followed shortly by the Reconciliation Act of 2010 (H.R. 4872) on 30 March, both designed to overhaul the system of healthcare to address problems with access to medical help and drug reimbursement. It is likely to be the mo... mehr

Hit by the Infamous Patent Cliff, Big Pharma Strategize Counter Measures for the Future

Summary

GlobalData’s report, 'Hit by the Infamous Patent Cliff, Big Pharma Strategize Counter Measures for the Future” provides key update on the much awaited 'patent cliff”, the term coined for the cumulative patent expirations from 2009-15 of blockbuster pharmaceutical drugs, and its effects on the pharmaceutical industr... mehr

Paradigm Shift in R&D from Small Molecules to Biologics and Need for More Efficient Logistics Infrastructure

Summary

GlobalData’s report, 'Paradigm Shift in R&D from Small Molecules to Biologics and Need for More Efficient Logistics Infrastructure” provides key update on the paradigm shift of comapnies from small molecules to biologics and the need to more robust and efficient logistics infrastructure.<... mehr

Parenteral Nutrition Market to 2017 - Home Care Sector To Witness Strong Market Growth

Summary

GBI Research has released its latest research, 'Parenteral Nutrition Market to 2017 - Home Care Sector to Witness Strong Market Growth”. It provides in-depth analysis of the market size and drivers and barriers that affect the global parenteral nutrition (PN) market. The report analyzes the markets for parenteral nutrit... mehr

Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q1 2011

Summary

GlobalData's 'Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q1 2011” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&A) and financing in the pharmaceutical and healthcare market. The report provides deta... mehr

Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals, April 2011

Summary

GlobalData's 'Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals, April 2011” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides detailed i... mehr

Introduction
Pharmaceuticals Logistics Spending in Australia to 2014 assesses prospects for logistics in pharmaceutical industry. It provides information on total logistics (by value) with respect to nature of sourcing & logistics activity. The databook also splits transport logistics by mode of transport, destination and shipment. It concludes with a snapshot of logistics & transport spending in Asia-Pacific.

Sc... mehr

Introduction
Pharmaceuticals Logistics Spending in Austria to 2014 assesses the prospects for logistics in pharmaceutical industry. It provides information on total logistics (by value) with respect to nature of sourcing and logistics activity. The databook also splits transport logistics by mode of transport, destination and shipment. It concludes with a snapshot of logistics and transport spending in Europe.

Scope
mehr

Introduction
Pharmaceuticals Logistics Spending in Belgium to 2014 assesses the prospects for logistics in pharmaceutical industry. It provides information on total logistics (by value) with respect to nature of sourcing and logistics activity. The databook also splits transport logistics by mode of transport, destination and shipment. It concludes with a snapshot of logistics and transport spending in Europe.

Scope
mehr

Introduction
Pharmaceuticals Logistics Spending in Brazil to 2014 assesses the prospects for logistics in pharmaceutical industry. It provides information on total logistics (by value) with respect to nature of sourcing & logistics activity. It also splits transport logistics by mode of transport, destination & shipment. It concludes with a snapshot of logistics & transport spending in South & Central America.
... mehr

Introduction
Pharmaceuticals Logistics Spending in Canada to 2014 assesses the prospects for logistics in pharmaceutical industry. It provides information on total logistics (by value) with respect to nature of sourcing and logistics activity. The databook also splits transport logistics by mode of transport, destination and shipment. It concludes with a snapshot of logistics & transport spending in Americas.

Scope mehr

Introduction
Pharmaceuticals Logistics Spending in China to 2014 assesses prospects for logistics in pharmaceutical industry. It provides information on total logistics (by value) with respect to nature of sourcing and logistics activity. The databook also splits transport logistics by mode of transport, destination and shipment. It concludes with a snapshot of logistics & transport spending in Asia-Pacific.

Scope mehr

Introduction
Pharmaceuticals Logistics Spending in France to 2014 assesses the prospects for logistics in pharmaceutical industry. It provides information on total logistics (by value) with respect to nature of sourcing and logistics activity. The databook also splits transport logistics by mode of transport, destination and shipment. It concludes with a snapshot of logistics & transport spending in Europe.

Scope
mehr

Introduction
Pharmaceuticals Logistics Spending in Germany to 2014 assesses the prospects for logistics in pharmaceutical industry. It provides information on total logistics (by value) with respect to nature of sourcing and logistics activity. The databook also splits transport logistics by mode of transport, destination and shipment. It concludes with a snapshot of logistics and transport spending in Europe.

Scope
mehr

Introduction
Pharmaceuticals Logistics Spending in Hungary to 2014 assesses the prospects for logistics in pharmaceutical industry. It provides information on total logistics (by value) with respect to nature of sourcing and logistics activity. The databook also splits transport logistics by mode of transport, destination and shipment. It concludes with a snapshot of logistics and transport spending in Europe.

Scope
mehr

Introduction
Pharmaceuticals Logistics Spending in India to 2014 assesses prospects for logistics in pharmaceutical industry. It provides information on total logistics (by value) with respect to nature of sourcing and logistics activity. The databook also splits transport logistics by mode of transport, destination and shipment. It concludes with a snapshot of logistics and transport spending in Asia-Pacific.

Scope
mehr

Introduction
Pharmaceuticals Logistics Spending in Italy to 2014 assesses the prospects for logistics in pharmaceutical industry. It provides information on total logistics (by value) with respect to nature of sourcing and logistics activity. The databook also splits transport logistics by mode of transport, destination and shipment. It concludes with a snapshot of logistics and transport spending in Europe.

Scope
L... mehr

Introduction
Pharmaceuticals Logistics Spending in Japan to 2014 assesses prospects for logistics in pharmaceutical industry. It provides information on total logistics (by value) with respect to nature of sourcing and logistics activity. The databook also splits transport logistics by mode of transport, destination and shipment. It concludes with a snapshot of logistics and transport spending in Asia-Pacific.

Scope
mehr

Introduction
Pharmaceuticals Logistics Spending in Malaysia to 2014 assesses prospects for logistics in pharmaceutical industry. It provides information on total logistics (by value) with respect to nature of sourcing & logistics activity. The databook also splits transport logistics by mode of transport, destination and shipment. It concludes with a snapshot of logistics & transport spending in Asia-Pacific.

Sco... mehr

Introduction
Pharmaceuticals Logistics Spending in Mexico to 2014 assesses the prospects for logistics in pharmaceutical industry. It provides information on total logistics (by value) with respect to nature of sourcing and logistics activity. The databook also splits transport logistics by mode of transport, destination, and shipment. It concludes with a snapshot of logistics & transport spending in Americas.

Scope<... mehr

Introduction
Pharmaceuticals Logistics Spending in Poland to 2014 assesses the prospects for logistics in pharmaceutical industry. It provides information on total logistics (by value) with respect to nature of sourcing and logistics activity. The databook also splits transport logistics by mode of transport, destination and shipment. It concludes with a snapshot of logistics and transport spending in Europe.

Scope
... mehr

Introduction
Pharmaceuticals Logistics Spending in Portugal to 2014 assesses the prospects for logistics in pharmaceutical industry. It provides information on total logistics (by value) with respect to nature of sourcing and logistics activity. The databook also splits transport logistics by mode of transport, destination and shipment. It concludes with a snapshot of logistics & transport spending in Europe.

Scope mehr

Introduction
Pharmaceuticals Logistics Spending in Russia to 2014 assesses the prospects for logistics in pharmaceutical industry. It provides information on total logistics (by value) with respect to nature of sourcing and logistics activity. The databook also splits transport logistics by mode of transport, destination and shipment. It concludes with a snapshot of logistics and transport spending in Europe.

Scope
... mehr

Introduction
Pharmaceuticals Logistics Spending in Singapore to 2014 assesses prospects for logistics in pharmaceutical industry. It provides information on total logistics (by value) with respect to nature of sourcing & logistics activity. The databook also splits transport logistics by mode of transport, destination and shipment. It concludes with a snapshot of logistics & transport spending in Asia-Pacific.

Sc... mehr

Introduction
Pharmaceuticals Logistics Spending in Spain to 2014 assesses the prospects for logistics in pharmaceutical industry. It provides information on total logistics (by value) with respect to nature of sourcing and logistics activity. The databook also splits transport logistics by mode of transport, destination and shipment. It concludes with a snapshot of logistics and transport spending in Europe.

Scope
L... mehr

Introduction
Pharmaceuticals Logistics Spending in Switzerland to 2014 assesses the prospects for logistics in pharmaceutical industry. It provides information on total logistics (by value) with respect to nature of sourcing and logistics activity. The databook also splits transport logistics by mode of transport, destination & shipment. It concludes with a snapshot of logistics & transport spending in Europe.

Sc... mehr

Introduction
Pharmaceuticals Logistics Spending in the Netherlands to 2014 assesses the prospects for logistics pharmaceutical industry. It provides information on total logistics (by value) with respect to nature of sourcing & logistics activity.The databook also splits transport logistics by mode of transport, destination and shipment. It concludes with a snapshot of logistics & transport spending in Europe.

Sc... mehr

Introduction
Pharmaceuticals Logistics Spending in the UK to 2014 assesses the prospects for logistics in pharmaceutical industry. It provides information on total logistics (by value) with respect to nature of sourcing and logistics activity. The databook also splits transport logistics by mode of transport, destination and shipment. It concludes with a snapshot of logistics and transport spending in Europe.

Scope
... mehr

Introduction
Pharmaceuticals Logistics Spending in United Arab Emirates to 2014. It provides information on total logistics (by value) with respect to nature of sourcing and logistics activity. The databook also splits transport logistics by mode of transport, destination, and shipment.

Scope
Logistics spending by nature of sourcing -In-house, outsourced, and contract logistics spending by activity (transport, ware... mehr

Introduction
Pharmaceuticals Logistics Spending in the US to 2014 assesses the prospects for logistics in pharmaceutical industry. It provides information on total logistics (by value) with respect to nature of sourcing and logistics activity. The databook also splits transport logistics by mode of transport, destination and shipment. It concludes with a snapshot of logistics & transport spending in Americas.

Scope mehr

Introduction

This brief provides a detailed study of the UK healthcare cash plan market, with information on market size and profitability. The brief also discusses consumer and distribution trends in the market, identifying the consumer segments most likely to buy insurance and provides a forecast on the size of the market from 2011-2015.

Features and benefits

* Data on market size, product penetration ... mehr

Gilenya (Fingolimod), Laquinimod and Cladribine - Impact on the Multiple Sclerosis (MS) Treatment Landscape

Summary

GlobalData’s report, 'Gilenya (Fingolimod), Laquinimod and Cladribine - Impact on the Multiple Sclerosis (MS) Treatment Landscape” provides key information on current available treatment of Multiple Sclerosis, drivers and barriers for the future MS market and how the novel pipeline molecules will ... mehr

Neue Produktentwickluneng bei Gesundheitsprodukten 2011

Innovation in Consumer Health evolves through novel options in single-dose, convenient and improved delivery mechanisms. Consumers seek quick and effective solutions to prevent and treat minor ailments, while manufacturers develop new products to meet those demands. Improved formulations provide relief via novel delivery mechanisms that make drugs easy to swallow or appl... mehr

Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - March 2011

Summary

GlobalData's 'Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals — March 2011” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides de... mehr

Pharmaceutical & Healthcare Annual Deals Analysis 2011

Summary

GlobalData's 'Pharmaceutical & Healthcare Annual Deals Analysis 2011” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&A) and financing in the pharmaceutical and healthcare market. The report provides detailed information on Partnerships, Licensing Agreements, M&As, Equity... mehr

Introduction

Healthcare expenditure is growing fast in all markets, driven by aging populations, a growing prevalence of chronic diseases, expanding government healthcare coverage, use of expensive drugs. Also, as a result of the economic downturn, healthcare funding is under increased scrutiny by governments in developed markets looking to pay down their debts.

Features and benefits

* An overview of hea... mehr

Telaprevir and Boceprevir: The First Generation Protease Inhibitors Boosts Response Rates to Standard Chronic Hepatitis C Treatment

Summary

Global Data'Telaprevir and Boceprevir: The First Generation Protease Inhibitors Boosts Response Rates to Standard Chronic Hepatitis C Treatment' provides an analysis of Vertex pharmaceuticals hepatitis C drug Telaprevir and Merck’s Boceprevir an oral anti-viral therapies tha... mehr

Vertex’s VX770 Is Poised To Become The First Targeted Therapy To Be Approved In Cystic Fibrosis

Summary

GlobalData’s report, 'Vertex’s VX770 Is Poised To Become The First Targeted Therapy To Be Approved In Cystic Fibrosis” provides key information on current available treatment of Cystic Fibrosis and importance Vertex’s VX770 as a target therapy in Cystic Fibrosis market.

Scope

- Dat... mehr

Will 2011 Spell a Brighter Year for the Pharmaceutical Companies?

Summary

GlobalData’s report, 'Will 2011 Spell a Brighter Year for the Pharmaceutical Companies?” provides information on the 2011 pharmaceutical industry scenario and the factors that will shape and drive the industry in 2011. This report features approval trends, R&D spend and important features of major therapeutic areas. The report also hi... mehr

Two very important active ingredients in cough and cold products were the subject of heated regulatory discussion in 2010. Pseudoephedrine (PSE), a powerful decongestant, attracted criticism for its role in the illegal manufacture of methamphetamines, psychoactive stimulants that have a high propensity for addiction and abuse. The US government recognised this danger and passed the Combat Methamphetamine Epidemic Act (2006), which restr... mehr

Manufacturing of Solid Dosage Forms - Transformation in Manufacturing Concepts and Expanding Contract Manufacturers’ Production Capacity May Force Regulatory Bodies to Re-Design Guidelines on Quality Standards


Summary


GBI Research's report, 'Manufacturing of Solid Dosage Forms - Transformation in Manufacturing Concepts and Expanding Contract Manufacturers’ Production Capacity May Force Regulatory Bo... mehr

Novel Targeted Therapies Hold the Promise of Cure for Parkinson’s Disease (PD)

Summary

GlobalData’s report, 'Novel Targeted Therapies Hold the Promise of Cure for Parkinson’s Disease (PD) ” provides key information on current available treatment of Parkinson’s Disease and how the novel pipeline molecules will drive the global market

Scope

- Data and information on noval therapy on ... mehr

Introduction

Pharma is facing slowing sales growth in the developed pharmaceutical markets, driven by increasing generic competition. However, the speed and severity of brand erosion is by no means equal across countries, prescribing setting, therapy area and formulation type; factors which are of key importance when managing and forecasting branded drug sales.

Features and benefits

* Analyzes brand eros... mehr

Introduction

Prescription pharmaceutical sales in the world’s major markets (US, France, Germany, Italy, Spain, the UK, Japan, Australia, Brazil, Russia, China and India) totaled $555bn in 2009, having grown by 6.3% during 2008—09, and at a compound annual growth rate (CAGR) of 5.6% between 2005 and 2009.

Features and benefits

* Examines the prescription pharmaceutical sales growth trends across ... mehr

Introduction

As further statutory price cuts and 'expanded and accelerated” price disclosure is applied to substitutable medicines by the Australian Pharmaceutical Benefits Scheme (PBS), downward pricing pressures will affect some industry sectors more than others.

Features and benefits

* Overview of the role and function of the Pharmaceutical Benefits Scheme in Australia.
* Summary of all major a... mehr

Strong Pipeline Characterized with Novel Therapies will Drive the Methicillin-Resistant Staphylococcus Aureus (MRSA) Market

Summary

GlobalData’s report, 'Strong Pipeline Characterized with Novel Therapies will drive the Methicillin-Resistant Staphylococcus Aureus (MRSA) Market” provides key information on current available treatment of MRSA and how the novel pipeline molecules will drive the global market of MR... mehr

Tivozanib: Newer VEGF Inhibitors Represent A Paradigm Shift In Renal Cell Carcinoma Therapy

Summary

GlobalData’s report, 'Tivozanib: Newer VEGF Inhibitors Represent A Paradigm Shift In Renal Cell Carcinoma Therapy” provides key information on current available treatment of Renal Cancer and Newer VEGF Inhibitors will drive the global market of Renal Cancer

Scope

- Data and information on ... mehr

Introduction

This analysis examines the historical and forecast performance for Eisai in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs.

Features and benefits

* Gain insight into Eisai's strategic outlook across the next 6 years
* Analyze comp... mehr

Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - January 2011

Summary

GlobalData's 'Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals — January 2011” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provide... mehr

Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals — Q4 2010

Summary

GlobalData's 'Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals — Q4 2010” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides de... mehr

Introduction

This report discusses market dynamics, drivers, resistors and future outlook of CMO industry in China. It also includes manufacturing capabilities, growth strategies, SWOT analysis of the top 10 CMOs. Other leading players are also examined.
Features and benefits

* Analyze the competitive positioning and outlook of the leading Chinese CMOs.* Assess the projected growth of the CMO market in China.... mehr

Introduction

This analysis examines the historical and forecast performance for Abbott in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs.
Features and benefits

* Gain insight into Abbott's strategic outlook across the next 6 years.* Analyze company sales... mehr

Introduction

This analysis examines the historical and forecast performance for Alcon in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs.
Features and benefits

* Gain insight into Alcon's strategic outlook across the next 6 years* Analyze company sales fo... mehr

Introduction

This analysis examines the historical and forecast performance for Apotex in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs.
Features and benefits

* Gain insight into Apotex's strategic outlook across the next 6 years* Analyze company sales ... mehr

Introduction

This analysis examines the historical and forecast performance for Baxter in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs.
Features and benefits

* Gain insight into Baxter's strategic outlook across the next 6 years* Analyze company sales ... mehr

Introduction

This analysis examines the historical and forecast performance for Boehringer Ingelheim in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs.
Features and benefits

* Gain insight into Boehringer Ingelheim's strategic outlook across the next 6 y... mehr

Introduction

Pharma is facing slowing sales growth in the developed pharmaceutical markets, driven by increasing generic competition. However, the speed and severity of brand erosion is by no means equal across countries, prescribing setting, therapy area and formulation type; factors which are of key importance when managing and forecasting branded drug sales.
Features and benefits

* Analyzes brand erosion (i... mehr

Introduction

This analysis examines the historical and forecast performance for Bristol-Myers Squibb in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs.
Features and benefits

* Gain insight into Bristol-Myers Squibb's strategic outlook across the next 6 y... mehr

Introduction

This analysis examines the historical and forecast performance for Celgene in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs.
Features and benefits

* Gain insight into Celgene's strategic outlook across the next 6 years* Analyze company sale... mehr

Introduction

This analysis examines the historical and forecast performance for Cephalon in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs.
Features and benefits

* Gain insight into Cephalon's strategic outlook across the next 6 years* Analyze company sa... mehr

Introduction

This analysis examines the historical and forecast performance for CSL in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs.
Features and benefits

* Gain insight into CSL's strategic outlook across the next 6 years* Analyze company sales foreca... mehr

Introduction

This analysis examines the historical and forecast performance for Daiichi Sankyo in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs.
Features and benefits

* Gain insight into Daiichi Sankyo's strategic outlook across the next 6 years* Analyz... mehr

Introduction

The Healthcare Market Map is a comprehensive interactive model, which assesses and analyses the logistics industry in the key Healthcare sectors across 13 European countries, covering historical, current and forecasted market values up to 2014. Country coverage: Austria, Belgium, France, Germany, Hungary, Italy, Netherlands, Poland, Portugal, Russia, Spain, Switzerland and UK.
Features and benefits

mehr

Introduction

The prescription pharma market in France was valued at $38.8bn in sales in 2009, having by 3.1% (CAGR; 2005—09). Key growth drivers include growing use of chronic high-value innovative treatments driven by an aging population, high public healthcare expenditure as proportion of total healthcare expenditure, physician preference for prescribing branded drugs as well as high patient brand loyalty.
Fea... mehr

Introduction

This analysis examines the historical and forecast performance for Lundbeck in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs.
Features and benefits

* Gain insight into Lundbeck's strategic outlook across the next 6 years* Analyze company sa... mehr

The prescription pharmaceutical market in India generated $7.1 billion in sales in 2009, with an annual growth rate of 18.1% between 2008 and 2009. Key growth drivers include India's growing economy, low operating costs, expanding health insurance coverage and healthcare expenditure especially among the middle classes. It is an overview of the Indian pharmaceutical market including socioeconomic trends, regulatory issues, market sizing,... mehr

Introduction
Emerging markets have represented important growth opportunities for the global pharmaceutical industry, but it has been unclear the extent to which this has been accompanied by growth in domestic innovation within these countries. This report examines the most prominent domestic innovators, assessing key research strategies, front-running candidates, scientific strengths, and patent portfolios.
Features and ben... mehr

Introduction

This analysis examines the historical and forecast performance for Johnson & Johnson in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs.
Features and benefits

* Gain insight into Johnson & Johnson's strategic outlook across the next 6... mehr

Macular Edema Therapeutics - Pipeline Assessment and Market Forecasts to 2017

Summary

GlobalData, the industry analysis specialist’s new report, 'Macular Edema Therapeutics - Pipeline Assessment and Market Forecasts to 2017” is an essential source of information and analysis on the global macular edema therapeutics market. The report identifies the key trends shaping and driving the global macular edema therape... mehr

Introduction

The analysis examines the historical and forecast performance for Mylan in the generic prescription pharmaceutical sector. The profile encompasses global company strategy and assessment of financial performance.
Features and benefits

* Gain insight in to Mylan's stategic outlook across the next 6 years.* Analyze company sales forecasts by therapy area, geography and formulation.
Highlights mehr

Introduction

The analysis examines the historical and forecast performance for Mylan in the generic prescription pharmaceutical sector. The profile encompasses global company strategy and assessment of financial performance.
Features and benefits

* Gain insight in to Mylan's stategic outlook across the next 6 years.* Analyze company sales forecasts by therapy area, geography and formulation.
Highlights mehr

Introduction

This analysis examines the historical and forecast performance for Otsuka in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs.
Features and benefits

* Gain insight into Otsuka's strategic outlook across the next 6 years* Analyze company sales ... mehr

Introduction

This analysis examines the historical and forecast performance for Otsuka in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs.
Features and benefits

* Gain insight into Otsuka's strategic outlook across the next 6 years* Analyze company sales ... mehr